[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 69 of about 69
1. Angulo Hervías E, Lample Lacasa C, Crespo Rodríguez AM, Yagüe Romeo D: [Primary mesenchymal chondrosarcoma of the mediastinum]. Radiologia; 2007 Sep-Oct;49(5):358-61
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Primary mesenchymal chondrosarcoma of the mediastinum].
  • They are presented one mediastinal chondrosarcoma case in adult patient of patho-anatomical diagnosis.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Mediastinal Neoplasms / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17910876.001).
  • [ISSN] 0033-8338
  • [Journal-full-title] Radiología
  • [ISO-abbreviation] Radiologia
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


2. Cai L, Gao ZF, Huang XY: [Clinicopathology analysis of mesenchymal chondrosarcoma in soft tissue]. Beijing Da Xue Xue Bao; 2006 Oct 18;38(5):501-5
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinicopathology analysis of mesenchymal chondrosarcoma in soft tissue].
  • OBJECTIVE: To investigate the clinicopathological and immunohistochemical characteristics of soft tissue mesenchymal chondrosarcoma.
  • METHODS: The clinical material, pathological and immunohistochemical characteristics (reaction to LCA, CD3, CD20, CD45RO, CD79a, CD99, NSE, S-100, Syn, CgA, CK7, CK19, EMA, Coll-II, Sarcomeric-Actin, Desmin, Ki-67,P53) of 2 cases of soft tissue mesenchymal chondrosarcoma in Jishuitan Hospital between 1995 and 2005 were reviewed and followed up.
  • The histological characteristic features showed undifferentiated small cells together with islands of chondrosarcoma; there was hemangiopericytoma-like arrangement of small cells.
  • CONCLUSION: Mesenchymal chondrosarcoma of soft tissue has the characteristics of primary mesenchyme which differentiates to congenital cartilage.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Antigens, CD20 / analysis. Antigens, CD3 / analysis. Desmin / analysis. Female. Humans. Immunohistochemistry. Keratin-7 / analysis. Ki-67 Antigen / analysis. Tumor Suppressor Protein p53 / analysis

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17068623.001).
  • [ISSN] 1671-167X
  • [Journal-full-title] Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
  • [ISO-abbreviation] Beijing Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD20; 0 / Antigens, CD3; 0 / Desmin; 0 / Keratin-7; 0 / Ki-67 Antigen; 0 / Tumor Suppressor Protein p53
  •  go-up   go-down


3. Oh BG, Han YH, Lee BH, Kim SY, Hwang YJ, Seo JW, Kim YH, Cha SJ, Hur G, Joo M: Primary extraskeletal mesenchymal chondrosarcoma arising from the pancreas. Korean J Radiol; 2007 Nov-Dec;8(6):541-4
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary extraskeletal mesenchymal chondrosarcoma arising from the pancreas.
  • We report here on a case of primary extraskeletal mesenchymal chondrosarcoma that arose from the pancreas.
  • Following excision of the mass, it was pathologically confirmed to be primary extraskeletal mesenchymal chondrosarcoma that arose from the pancreas.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Pancreatic Neoplasms / diagnosis
  • [MeSH-minor] Abdominal Pain / etiology. Adult. Contrast Media / administration & dosage. Diagnosis, Differential. Humans. Iohexol / analogs & derivatives. Male. Necrosis. Pancreas / pathology. Pancreas / radiography. Portal Vein / radiography. Radiographic Image Enhancement / methods. Rare Diseases. Retroperitoneal Space / radiography. Splenic Vein / radiography. Tomography, X-Ray Computed / methods

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Imaging. 2003 May-Jun;27(3):187-90 [12727057.001]
  • [Cites] J Clin Oncol. 1985 Jun;3(6):858-63 [2409241.001]
  • [Cites] Cancer. 1986 Jun 15;57(12):2444-53 [3697943.001]
  • [Cites] Acta Cytol. 1990 Jul-Aug;34(4):529-32 [2375221.001]
  • [Cites] Cancer. 1959 Nov-Dec;12:1142-57 [14416919.001]
  • [Cites] Radiology. 1993 Mar;186(3):819-26 [8430193.001]
  • [Cites] Acta Cytol. 1995 Nov-Dec;39(6):1237-43 [7484001.001]
  • [Cites] Radiat Med. 1999 May-Jun;17(3):239-41 [10440114.001]
  • [Cites] J Bone Joint Surg Am. 1964 Jun;46:747-54 [14161087.001]
  • [Cites] Acta Obstet Gynecol Scand. 1989;68(5):467-8 [2520797.001]
  • (PMID = 18071285.001).
  • [ISSN] 1229-6929
  • [Journal-full-title] Korean journal of radiology
  • [ISO-abbreviation] Korean J Radiol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] 0 / Contrast Media; 4419T9MX03 / Iohexol; 712BAC33MZ / iopromide
  • [Other-IDs] NLM/ PMC2627457
  •  go-up   go-down


Advertisement
4. Naama O, Ajja A, El Moustarchid B, Albouzidi A, Asri A, Belhachmi A, Akhaddar A, Gazzaz M, Kadiri B, Labraimi A, Boucetta M: [Spheno-orbital mesenchymal chondrosarcoma. A case report]. J Fr Ophtalmol; 2007 Feb;30(2):211-5
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Spheno-orbital mesenchymal chondrosarcoma. A case report].
  • Mesenchymal chondrosarcoma is a highly malignant and extremely rare tumor of the orbit: only 18 cases have been reported to date.
  • We report a case of spheno-orbital mesenchymal chondrosarcoma in a 36-year-old woman presented with a 4-month history of progressive left exophthalmia and temporal mass.
  • Definitive histologic examination revealed mesenchymal chondrosarcoma.
  • [MeSH-major] Bone Neoplasms / surgery. Chondrosarcoma / surgery. Skull / surgery
  • [MeSH-minor] Adult. Combined Modality Therapy. Exophthalmos / etiology. Female. Humans. Magnetic Resonance Imaging. Radiotherapy / methods. Tomography, X-Ray Computed. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17318111.001).
  • [ISSN] 1773-0597
  • [Journal-full-title] Journal français d'ophtalmologie
  • [ISO-abbreviation] J Fr Ophtalmol
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


5. Bencheikh R, Benhammou A, Benbouzid MA, El Edghiri H, Boulaich M, Essakali L, Kzadri M: [Mesenchymal chondrosarcoma of the mandible]. Rev Stomatol Chir Maxillofac; 2007 Apr;108(2):156-8
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Mesenchymal chondrosarcoma of the mandible].
  • INTRODUCTION: Mesenchymal chondrosarcoma is a rare form of chondrosarcoma and mandibular localization is rare.
  • OBSERVATION: We report a case of mesenchymal chondrosarcoma of the mandible in a 23-year-old patient who consulted for a voluminous tumor of the right mandible.
  • The histological assessment showed zones of neoplastic cartilage and small ovoid cells, typical of mesenchymal chondrosarcoma.
  • DISCUSSION: Mesenchymal chondrosarcoma is a rare malignant tumor of skeletal and extra skeletal origin.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Mandibular Neoplasms / pathology
  • [MeSH-minor] Adult. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17350059.001).
  • [ISSN] 0035-1768
  • [Journal-full-title] Revue de stomatologie et de chirurgie maxillo-faciale
  • [ISO-abbreviation] Rev Stomatol Chir Maxillofac
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  •  go-up   go-down


6. Heyse TJ, Malcherczyk D, Moll R, Timmesfeld N, Wapelhorst J, Fuchs-Winkelmann S, Paletta JR, Schofer MD: CD44: survival and metastasis in chondrosarcoma. Osteoarthritis Cartilage; 2010 Jun;18(6):849-56
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] CD44: survival and metastasis in chondrosarcoma.
  • OBJECTIVE: Recent studies have shown abnormal expression of CD44s and some of its isoforms in many human malignancies, but little is known about the presence of CD44 in chondrosarcoma.
  • METHOD: Thirty paraffin-embedded chondrosarcoma samples were immunostained with monoclonal antibodies for CD44s, CD44v5 and CD44v6.
  • RESULTS: Among the 30 patients (median age 50 years) there were 22 conventional chondrosarcomas, two dedifferentiated chondrosarcomas, two extraskeletal chondrosarcomas, and one periostal, mesenchymal, clear cell and myxoid chondrosarcoma each.
  • CONCLUSIONS: Overexpression of CD44s correlated significantly with metastatic potential and with poorer survival in patients with chondrosarcoma.

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
  • (PMID = 20171296.001).
  • [ISSN] 1522-9653
  • [Journal-full-title] Osteoarthritis and cartilage
  • [ISO-abbreviation] Osteoarthr. Cartil.
  • [Language] ENG
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Antigens, CD44; 0 / Protein Isoforms
  •  go-up   go-down


7. Cesari M, Bertoni F, Bacchini P, Mercuri M, Palmerini E, Ferrari S: Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution. Tumori; 2007 Sep-Oct;93(5):423-7
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma. An analysis of patients treated at a single institution.
  • BACKGROUND: We analyzed clinical and treatment-related factors influencing the outcome of patients with mesenchymal chondrosarcoma (MC).
  • [MeSH-major] Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Bone Neoplasms / therapy. Chondrosarcoma, Mesenchymal / therapy
  • [MeSH-minor] Adult. Aged. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Male. Middle Aged. Prognosis. Retrospective Studies. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18038872.001).
  • [ISSN] 0300-8916
  • [Journal-full-title] Tumori
  • [ISO-abbreviation] Tumori
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


8. Pant R, Yasko AW, Lewis VO, Raymond K, Lin PP: Chondrosarcoma of the scapula: long-term oncologic outcome. Cancer; 2005 Jul 1;104(1):149-58
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chondrosarcoma of the scapula: long-term oncologic outcome.
  • BACKGROUND: Chondrosarcoma is the second most common primary sarcoma of bone.
  • In the current study, the authors reviewed the surgical experience and long-term oncologic outcomes of patients with chondrosarcoma arising in the scapula.
  • METHODS: The medical records of 29 consecutive patients with chondrosarcoma of the scapula were reviewed.
  • The tumors were classified histologically as Grade 1 (10 patients), Grade 2 (10 patients), Grade 3 (7 patients), dedifferentiated (1 patient), and mesenchymal (1 patient) (using the criteria of Evans et al.).
  • CONCLUSIONS: Patients who had localized chondrosarcoma of the scapula had a favorable long-term outcome, most likely due to the unique anatomic features that improved the likelihood of achieving wide surgical margins with limb-sparing surgery, despite the frequent presentation of locally advanced disease.
  • [MeSH-major] Bone Neoplasms / surgery. Chondrosarcoma / surgery. Scapula
  • [MeSH-minor] Adolescent. Adult. Aged. Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15895373.001).
  • [ISSN] 0008-543X
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


9. Bueno MR, De Carvalhosa AA, De Souza Castro PH, Pereira KC, Borges FT, Estrela C: Mesenchymal chondrosarcoma mimicking apical periodontitis. J Endod; 2008 Nov;34(11):1415-1419
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma mimicking apical periodontitis.
  • This report describes the case of a patient with mesenchymal chondrosarcoma in the region of tooth #18 that mimicked apical periodontitis.
  • Microscopic examination confirmed the diagnosis of mesenchymal chondrosarcoma.
  • This clinical case draws attention to the fact that endodontic lesions should be carefully evaluated because malignant tumors such as mesenchymal chondrosarcoma might mimic apical periodontitis.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Mandibular Neoplasms / diagnosis. Periapical Periodontitis / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18928860.001).
  • [ISSN] 1878-3554
  • [Journal-full-title] Journal of endodontics
  • [ISO-abbreviation] J Endod
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


10. Reyaz N, Ashraf M: Intracranial extra-skeletal mesenchymal chondrosarcoma. J Ayub Med Coll Abbottabad; 2006 Apr-Jun;18(2):86-7
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intracranial extra-skeletal mesenchymal chondrosarcoma.
  • Intracranial Mesenchymal Chondrosarcoma is a very rare and uncommon entity that affects young adults.
  • The clinical, radiological preoperative diagnosis was a meningioma, on histological examination it turned out to be mesenchymal chondrosarcoma of tentorial region in posterior fossa, uncommon site for this entity.
  • [MeSH-major] Brain Neoplasms / diagnosis. Chondrosarcoma, Mesenchymal / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16977825.001).
  • [ISSN] 1025-9589
  • [Journal-full-title] Journal of Ayub Medical College, Abbottabad : JAMC
  • [ISO-abbreviation] J Ayub Med Coll Abbottabad
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Pakistan
  • [Number-of-references] 10
  •  go-up   go-down


11. Angotti-Neto H, Cunha LP, Oliveira AV, Monteiro ML: Mesenchymal chondrosarcoma of the orbit. Ophthal Plast Reconstr Surg; 2006 Sep-Oct;22(5):378-82
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma of the orbit.
  • PURPOSE: To describe a patient with mesenchymal chondrosarcoma of the orbit, review clinical and imaging findings, and refine the differential diagnosis from other tumors of the orbit.
  • The patient was diagnosed with mesenchymal chondrosarcoma of the orbit only after orbitotomy and subsequent histopathologic study.
  • CONCLUSIONS: Mesenchymal chondrosarcoma is a rare malignant tumor of the orbit capable of mimicking several other lesions.
  • Prognosis for patients with orbital mesenchymal chondrosarcoma is tentative at best, in part because of the rarity of the lesion.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Orbital Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Ophthalmologic Surgical Procedures / methods. Radiotherapy, Adjuvant. Tomography, X-Ray Computed

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16985424.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


12. Bu X, Dai X: Primary mesenchymal chondrosarcoma of the pancreas. Ann R Coll Surg Engl; 2010 Apr;92(3):W10-2
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary mesenchymal chondrosarcoma of the pancreas.
  • Extraskeletal chondrosarcomas are rare and there is only one reported case of primary pancreatic chondrosarcoma.
  • The mass was completely excised, and the histopathological diagnosis was primary mesenchymal pancreatic chondrosarcoma.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Pancreatic Neoplasms / diagnosis
  • [MeSH-minor] Adult. Female. Humans. Neoplasm Recurrence, Local / radiography. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20412660.001).
  • [ISSN] 1478-7083
  • [Journal-full-title] Annals of the Royal College of Surgeons of England
  • [ISO-abbreviation] Ann R Coll Surg Engl
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  •  go-up   go-down


13. Okamoto Y, Minami M, Ueda T, Inadome Y, Tatsumura M, Sakane M: Extraskeletal mesenchymal chondrosarcoma of the cervical meninx. Radiat Med; 2007 Aug 1;25(7):355-8
Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal mesenchymal chondrosarcoma of the cervical meninx.
  • We report a case of recurrent mesenchymal chondrosarcoma in the cervical paravertebral region that was diagnosed preoperatively by imaging studies.
  • This discrepancy between CT and MRI was well correlated with pathological findings of mesenchymal chondrosarcoma and suggested this entity.
  • [MeSH-major] Cervical Vertebrae. Chondrosarcoma, Mesenchymal / diagnosis. Spinal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Contrast Media. Diagnosis, Differential. Gadolinium DTPA. Humans. Magnetic Resonance Imaging. Male. Neoplasm Recurrence, Local. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Neck Injuries and Disorders.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17705006.001).
  • [ISSN] 0288-2043
  • [Journal-full-title] Radiation medicine
  • [ISO-abbreviation] Radiat Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


14. Kathiravel Y, Finnis ND: Primary falcine chondrosarcoma. J Clin Neurosci; 2008 Dec;15(12):1406-9
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary falcine chondrosarcoma.
  • We present a patient with a classic falcine chondrosarcoma and review the radiological features that may aid in a pre-operative diagnosis, as well as the adjuvant treatment options.
  • Intracranial chondrosarcomas that occur above the skull base tend to be of the mesenchymal variety.
  • [MeSH-major] Bone Neoplasms / pathology. Chondrosarcoma / pathology
  • [MeSH-minor] Adult. Chondrocytes / pathology. Chondrocytes / ultrastructure. Female. Frontal Lobe / pathology. Frontal Lobe / surgery. Humans. Magnetic Resonance Imaging / methods. Parietal Lobe / pathology. Parietal Lobe / surgery

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18842412.001).
  • [ISSN] 0967-5868
  • [Journal-full-title] Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
  • [ISO-abbreviation] J Clin Neurosci
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Scotland
  •  go-up   go-down


15. Liu M, Qin W, Yin Z: An unusual case of primary mesenchymal chondrosarcoma in orbit with intracranial extension. Clin Imaging; 2010 Sep-Oct;34(5):379-81
Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An unusual case of primary mesenchymal chondrosarcoma in orbit with intracranial extension.
  • An unusual case of primary orbital mesenchymal chondrosarcoma with intracranial extension is reported, with special emphasis on the radiological findings.
  • [MeSH-major] Brain / pathology. Brain / radiography. Chondrosarcoma, Mesenchymal / diagnosis. Magnetic Resonance Imaging / methods. Orbital Neoplasms / diagnosis. Tomography, X-Ray Computed / methods
  • [MeSH-minor] Adult. Contrast Media. Diagnosis, Differential. Female. Follow-Up Studies. Gadolinium DTPA. Humans. Image Enhancement / methods. Neoplasm Invasiveness. Orbit / pathology. Orbit / radiography. Orbit / surgery. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • MedlinePlus Health Information. consumer health - MRI Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20813303.001).
  • [ISSN] 1873-4499
  • [Journal-full-title] Clinical imaging
  • [ISO-abbreviation] Clin Imaging
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Contrast Media; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


16. Mohammadinezhad C: Chondrosarcoma of the jaw. J Craniofac Surg; 2009 Nov;20(6):2097-100
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chondrosarcoma of the jaw.
  • Chondrosarcoma of the maxillofacial region is a rare tumor.
  • The classification of this tumor is based on histologic grades (1, 2, or 3) or variant including clear cell, differentiated, myxoid, and mesenchymal chondrosarcomas.
  • The most acceptable choice of treatment of the chondrosarcoma is wide resection.
  • However, lifelong follow-up is essential because chondrosarcoma shows a high incidence of local recurrence as well as regional and distant metastasis more than 2 decades later.
  • This study presents 2 cases of chondrosarcoma with a long-term follow-up.
  • [MeSH-major] Chondrosarcoma / pathology. Mandibular Neoplasms / pathology. Maxillary Neoplasms / pathology
  • [MeSH-minor] Adult. Fatal Outcome. Female. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / surgery. Nose. Orbital Implants. Prostheses and Implants. Skull Base Neoplasms / secondary. Skull Base Neoplasms / surgery

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19881362.001).
  • [ISSN] 1536-3732
  • [Journal-full-title] The Journal of craniofacial surgery
  • [ISO-abbreviation] J Craniofac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


17. Salvati M, Caroli E, Frati A, Piccirilli M, Agrillo A, Brogna C, Occhiogrosso G, Giangaspero F: Central nervous system mesenchymal chondrosarcoma. J Exp Clin Cancer Res; 2005 Jun;24(2):317-24
MedlinePlus Health Information. consumer health - Childhood Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Central nervous system mesenchymal chondrosarcoma.
  • Central nervous system mesenchymal chondrosarcomas are rare malignant tumors that constitute a separate entity from the classical chondrosarcoma and myxoid variant.
  • We describe two rare examples of intracranial mesenchymal chondrosarcoma with a review of the literature, in an attempt to clarify the clinical characteristics, prognosis and treatment of choice of these unusual tumors.
  • [MeSH-major] Brain Neoplasms / diagnosis. Chondrosarcoma, Mesenchymal / diagnosis
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Agents. Cartilage / pathology. Cell Differentiation. Central Nervous System Neoplasms / diagnosis. Central Nervous System Neoplasms / mortality. Central Nervous System Neoplasms / therapy. Chemotherapy, Adjuvant. Child. Child, Preschool. Female. Humans. Infant. Magnetic Resonance Imaging. Male. Middle Aged. Prognosis. Time Factors. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16110767.001).
  • [ISSN] 0392-9078
  • [Journal-full-title] Journal of experimental & clinical cancer research : CR
  • [ISO-abbreviation] J. Exp. Clin. Cancer Res.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


18. Bonavolonta P, Strianese D, Maria Luisa Vecchione MM, Staibano S: A challenging case of primary orbital mesenchymal chondrosarcoma. Orbit; 2010 Oct;29(5):281-3
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A challenging case of primary orbital mesenchymal chondrosarcoma.
  • Mesenchymal chondrosarcoma is an uncommon lesion of the bone and extraskeletal tissue involving very rarely the orbit.
  • Histopathological features of this lesion include: undifferentiated mesenchymal cells with islands of mature hyaline cartilage.
  • We present a case of a 23-year-old man with primary orbital mesenchymal chondrosarcoma (OMC) with an uncommon management.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Orbital Neoplasms / pathology
  • [MeSH-minor] Biomarkers, Tumor / analysis. Humans. Magnetic Resonance Imaging. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20572753.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


19. Hashimoto N, Ueda T, Joyama S, Araki N, Beppu Y, Tatezaki S, Matsumoto S, Nakanishi K, Tomita Y, Yoshikawa H: Extraskeletal mesenchymal chondrosarcoma: an imaging review of ten new patients. Skeletal Radiol; 2005 Dec;34(12):785-92
Genetic Alliance. consumer health - TEN.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal mesenchymal chondrosarcoma: an imaging review of ten new patients.
  • OBJECTIVE: Extraskeletal mesenchymal chondrosarcoma (EMC) is a rare soft-tissue tumor that most arises in young adults.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnostic imaging. Chondrosarcoma, Mesenchymal / pathology. Soft Tissue Neoplasms / diagnostic imaging. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Aged. Female. Forearm. Humans. Japan. Leg. Magnetic Resonance Imaging. Male. Retrospective Studies. Thigh. Tomography, X-Ray Computed. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Neurol. 1999 Jul;52(1):50-3 [10390173.001]
  • [Cites] Radiology. 1993 Mar;186(3):819-26 [8430193.001]
  • [Cites] Cancer. 1983 Apr 1;51(7):1230-7 [6825046.001]
  • [Cites] Skeletal Radiol. 1980;5(4):263-6 [7209584.001]
  • [Cites] Cancer. 1971 Sep;28(3):605-15 [5096926.001]
  • [Cites] J Bone Joint Surg Am. 1980 Mar;62(2):189-94 [7358750.001]
  • [Cites] Br J Ophthalmol. 1974 Oct;58(10 ):882-7 [4451652.001]
  • [Cites] Neuroradiology. 1997 Apr;39(4):296-301 [9144681.001]
  • [Cites] Arch Pathol. 1973 May;95(5):336-40 [4694076.001]
  • [Cites] Cancer. 1986 Jun 15;57(12 ):2444-53 [3697943.001]
  • [Cites] Cancer. 1959 Nov-Dec;12:1142-57 [14416919.001]
  • [Cites] Mod Pathol. 2002 May;15(5):572-6 [12011263.001]
  • [Cites] Skeletal Radiol. 1997 Aug;26(8):501-4 [9297757.001]
  • (PMID = 16211384.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study
  • [Publication-country] Germany
  •  go-up   go-down


20. Anderson JT, Lucas GL: Extraskeletal mesenchymal chondrosarcoma of the forearm: a case report. J Hand Surg Am; 2007 Mar;32(3):389-92
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extraskeletal mesenchymal chondrosarcoma of the forearm: a case report.
  • Mesenchymal chondrosarcomas represent less than 10% of all chondrosarcomas.
  • This case report describes an extraskeletal mesenchymal chondrosarcoma involving the forearm.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / surgery. Soft Tissue Neoplasms / microbiology. Soft Tissue Neoplasms / surgery
  • [MeSH-minor] Adult. Combined Modality Therapy. Female. Forearm. Humans. Magnetic Resonance Imaging. Radiotherapy Dosage

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17336849.001).
  • [ISSN] 0363-5023
  • [Journal-full-title] The Journal of hand surgery
  • [ISO-abbreviation] J Hand Surg Am
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Razak AR, Gurney L, Kirkham N, Lee D, Neoh C, Verrill M: Mesenchymal chondrosarcoma of the orbit: an unusual site for a rare tumour. Eur J Cancer Care (Engl); 2010 Jul;19(4):551-3
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma of the orbit: an unusual site for a rare tumour.
  • Mesenchymal chondrosarcoma is a rare tumour with orbital involvement being an exceptional occurrence.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / therapy. Orbital Neoplasms / therapy
  • [MeSH-minor] Bone Neoplasms / pathology. Combined Modality Therapy / methods. Humans. Male. Neoplasm Staging. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19686354.001).
  • [ISSN] 1365-2354
  • [Journal-full-title] European journal of cancer care
  • [ISO-abbreviation] Eur J Cancer Care (Engl)
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  •  go-up   go-down


22. Parmar C, Jojo A, Vachhani KC, Vijayan SN: Primary chondrosarcoma of the heart. Eur J Cardiothorac Surg; 2008 Mar;33(3):513-5
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary chondrosarcoma of the heart.
  • Primary cardiac chondrosarcoma is extremely rare with very few cases reported in the literature.
  • The histopathology of the excised mass revealed mesenchymal chondrosarcoma, confirmed by immunohistochemistry.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Heart Neoplasms / pathology
  • [MeSH-minor] Fatal Outcome. Humans. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18243009.001).
  • [ISSN] 1010-7940
  • [Journal-full-title] European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery
  • [ISO-abbreviation] Eur J Cardiothorac Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


23. Yassa M, Bahary JP, Bourguoin P, Bélair M, Berthelet F, Bouthillier A: Intra-parenchymal mesenchymal chondrosarcoma of the cerebellum: case report and review of the literature. J Neurooncol; 2005 Sep;74(3):329-31
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Intra-parenchymal mesenchymal chondrosarcoma of the cerebellum: case report and review of the literature.
  • On pathology, the lesion was found to be compatible with a mesenchymal chondrosarcoma.
  • Mesenchymal chondrosarcomas are neoplasms that rarely arise intra-cranially.
  • [MeSH-major] Cerebellar Neoplasms / pathology. Chondrosarcoma, Mesenchymal / pathology. Neoplasms, Second Primary / pathology
  • [MeSH-minor] Adult. Carcinoma, Papillary / pathology. Humans. Immunohistochemistry. Magnetic Resonance Imaging. Male. Thyroid Neoplasms / pathology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16187026.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Netherlands
  •  go-up   go-down


24. Font RL, Ray R, Mazow ML, Del Valle M: Mesenchymal chondrosarcoma of the orbit: a unique radiologic-pathologic correlation. Ophthal Plast Reconstr Surg; 2009 May-Jun;25(3):219-22
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma of the orbit: a unique radiologic-pathologic correlation.
  • PURPOSE: To report a unique radiologic-histopathologic correlation of mesenchymal chondrosarcoma of the orbit in a 24-year-old Asian woman.
  • Histopathologic examination of the orbital mass showed a biphasic pattern of a mesenchymal chondrosarcoma exhibiting features of a high-grade sarcoma with hemangiopericytoma pattern that corresponds to the radiopaque portion of the mass and areas of chondrosarcoma that correlated with the radiolucent component of the tumor.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Chondrosarcoma, Mesenchymal / radiography. Orbital Neoplasms / pathology. Orbital Neoplasms / radiography. Tomography, X-Ray Computed
  • [MeSH-minor] Asian Continental Ancestry Group. Chemotherapy, Adjuvant. Exophthalmos / etiology. Exophthalmos / radiography. Female. Follow-Up Studies. Humans. Orbit Evisceration. Radiotherapy, Adjuvant. Treatment Outcome. Young Adult

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - CT Scans.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19454935.001).
  • [ISSN] 1537-2677
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


25. Kaur A, Kishore P, Agrawal A, Gupta A: Mesenchymal chondrosarcoma of the orbit: a report of two cases and review of the literature. Orbit; 2008;27(1):63-7
Hazardous Substances Data Bank. VINCRISTINE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma of the orbit: a report of two cases and review of the literature.
  • Mesenchymal chondrosarcoma, an uncommon lesion in bone and extraskeletal tissue, is extremely rare in the orbit.
  • Two cases of orbital mesenchymal chondrosarcoma in young adults presenting with proptosis and diminution of vision are reported.
  • The diagnosis was established by histopathological examination in both cases, which showed undifferentiated mesenchymal cells with islands of cartilage.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Neoplasm Recurrence, Local / therapy. Orbital Neoplasms / pathology
  • [MeSH-minor] Adult. Antineoplastic Combined Chemotherapy Protocols / administration & dosage. Cyclophosphamide / administration & dosage. Dactinomycin / administration & dosage. Female. Humans. Male. Orbit Evisceration. Radiotherapy, Adjuvant. Reoperation. Vincristine / administration & dosage

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • Hazardous Substances Data Bank. CYCLOPHOSPHAMIDE .
  • Hazardous Substances Data Bank. DACTINOMYCIN .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18307151.001).
  • [ISSN] 1744-5108
  • [Journal-full-title] Orbit (Amsterdam, Netherlands)
  • [ISO-abbreviation] Orbit
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 1CC1JFE158 / Dactinomycin; 5J49Q6B70F / Vincristine; 8N3DW7272P / Cyclophosphamide; VAC protocol
  • [Number-of-references] 11
  •  go-up   go-down


26. Saito Y, Takemura S, Sakurada K, Sato S, Kayama T: [Intracranial extraskeletal mesenchymal chondrosarcoma arising from falx: a case report and literature review]. No Shinkei Geka; 2010 May;38(5):441-8
MedlinePlus Health Information. consumer health - Brain Tumors.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Intracranial extraskeletal mesenchymal chondrosarcoma arising from falx: a case report and literature review].
  • Intracranial extraskeletal mesenchymal chondrosarcoma is a very rare tumor that affects young adults.
  • We report a 31-year-old woman with a huge intracranial extraskeletal mesenchymal chondrosarcoma.
  • Pathologic examination revealed a mesenchymal chondrosarcoma.
  • We review previously reported cases of extraskeletal intracranial mesenchymal chondrosarcoma and discuss imaging diagnosis, treatment strategies, and outcome.
  • [MeSH-major] Brain Neoplasms / diagnosis. Brain Neoplasms / surgery. Chondrosarcoma, Mesenchymal / diagnosis. Chondrosarcoma, Mesenchymal / surgery. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / surgery
  • [MeSH-minor] Adult. Dura Mater. Female. Humans. Magnetic Resonance Imaging

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20522915.001).
  • [ISSN] 0301-2603
  • [Journal-full-title] No shinkei geka. Neurological surgery
  • [ISO-abbreviation] No Shinkei Geka
  • [Language] jpn
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 25
  •  go-up   go-down


27. D'Andrea G, Caroli E, Capponi MG, Scicchitano F, Osti MF, Bellotti C, Ferrante L: Retroperitoneal mesenchymal chondrosarcoma mimicking a large retroperitoneal sacral schwannoma. Neurosurg Rev; 2008 Apr;31(2):225-9
Genetic Alliance. consumer health - Schwannoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Retroperitoneal mesenchymal chondrosarcoma mimicking a large retroperitoneal sacral schwannoma.
  • We report a case of retroperitoneal chondrosarcoma in which preoperative radiological study induced to a possible diagnosis of sacral schwannoma.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Neurilemmoma / pathology. Retroperitoneal Neoplasms / pathology
  • [MeSH-minor] Adult. Electromyography. Female. Gait Disorders, Neurologic / etiology. Humans. Magnetic Resonance Imaging. Neurologic Examination. Neurosurgical Procedures. Pain / etiology. Sacrococcygeal Region. Sciatic Neuropathy / etiology. Spinal Nerve Roots / physiopathology. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Radiology. 1993 Mar;186(3):819-26 [8430193.001]
  • [Cites] Cancer. 1998 Nov 15;83(10 ):2105-19 [9827715.001]
  • [Cites] J Bone Joint Surg Am. 1964 Jun;46:747-54 [14161087.001]
  • [Cites] J Bone Joint Surg Br. 1979 Nov;61-B(4):395-400 [500746.001]
  • [Cites] Cancer. 1986 Jul 15;58(2):287-98 [3521830.001]
  • [Cites] Clin Orthop Relat Res. 1977 Jan-Feb;(122):157-64 [837602.001]
  • [Cites] Cancer Genet Cytogenet. 2005 Jun;159(2):151-4 [15899388.001]
  • [Cites] Neurosurgery. 1984 Jun;14(6):747-9 [6462413.001]
  • [Cites] Cancer. 1983 Aug 1;52(3):533-41 [6861090.001]
  • [Cites] Cancer. 2001 Apr 1;91(7):1201-12 [11283918.001]
  • [Cites] J Bone Joint Surg Am. 1987 Jan;69(1):100-5 [3543017.001]
  • [Cites] Clin Orthop Relat Res. 1986 Mar;(204):119-29 [3956003.001]
  • [Cites] J Bone Joint Surg Am. 1989 Sep;71(8):1158-65 [2777842.001]
  • [Cites] Cancer. 1986 Jul 15;58(2):278-86 [3719521.001]
  • [Cites] Cancer. 1971 Aug;28(2):461-6 [5566365.001]
  • [Cites] Clin Imaging. 2003 May-Jun;27(3):187-90 [12727057.001]
  • [Cites] Radiol Clin North Am. 1999 Jan;37(1):203-17, xii [10026739.001]
  • [Cites] J Bone Joint Surg Am. 1981 Oct;63(8):1248-57 [7287795.001]
  • [Cites] Cancer. 1980 Jan 1;45(1):149-57 [7350999.001]
  • [Cites] Spine (Phila Pa 1976). 1978 Sep;3(3):202-9 [715548.001]
  • [Cites] Arch Pathol. 1973 May;95(5):336-40 [4694076.001]
  • [Cites] Skeletal Radiol. 1995 Aug;24(6):409-16 [7481896.001]
  • [Cites] Cancer. 1996 Aug 15;78(4):745-50 [8756367.001]
  • [Cites] Cancer. 1986 Jun 15;57(12 ):2444-53 [3697943.001]
  • [Cites] Clin Orthop Relat Res. 1997 Apr;(337):226-39 [9137194.001]
  • (PMID = 17912561.001).
  • [ISSN] 0344-5607
  • [Journal-full-title] Neurosurgical review
  • [ISO-abbreviation] Neurosurg Rev
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


28. Amukotuwa SA, Choong PF, Smith PJ, Powell GJ, Thomas D, Schlicht SM: Femoral mesenchymal chondrosarcoma with secondary aneurysmal bone cysts mimicking a small-cell osteosarcoma. Skeletal Radiol; 2006 May;35(5):311-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Femoral mesenchymal chondrosarcoma with secondary aneurysmal bone cysts mimicking a small-cell osteosarcoma.
  • Mesenchymal chondrosarcoma is a rare but aggressive, high-grade malignancy of primitive cartilage-forming mesenchyme that arises most commonly from skeletal sites.
  • Initial imaging and histological evaluation of a core biopsy of the lesion suggested osteosarcoma of the distal right femur; after review, however, the correct diagnosis of mesenchymal chondrosarcoma was made.
  • [MeSH-major] Bone Cysts, Aneurysmal / diagnosis. Bone Cysts, Aneurysmal / etiology. Chondrosarcoma, Mesenchymal / complications. Chondrosarcoma, Mesenchymal / diagnosis. Femoral Neoplasms / complications. Femoral Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Humans. Male

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • Genetic Alliance. consumer health - Aneurysmal Bone Cysts.
  • Genetic Alliance. consumer health - Osteosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Semin Diagn Pathol. 1984 Aug;1(3):165-72 [6400634.001]
  • [Cites] Radiology. 1993 Mar;186(3):819-26 [8430193.001]
  • [Cites] Radiographics. 1998 Sep-Oct;18(5):1213-37; quiz 1244-5 [9747616.001]
  • [Cites] Skeletal Radiol. 1996 Feb;25(2):137-41 [8848742.001]
  • [Cites] Cancer. 1983 Apr 1;51(7):1230-7 [6825046.001]
  • [Cites] Radiology. 2002 Jun;223(3):731-7 [12034942.001]
  • [Cites] Clin Orthop Relat Res. 1981 Jul-Aug;(158):144-8 [7273513.001]
  • [Cites] Radiology. 1999 Sep;212(3):682-6 [10478232.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):644-9 [8642019.001]
  • [Cites] Cancer Genet Cytogenet. 2005 Jun;159(2):151-4 [15899388.001]
  • [Cites] Cancer. 1971 Sep;28(3):605-15 [5096926.001]
  • [Cites] Cancer. 2003 Aug 25;99(4):211-6 [12925982.001]
  • [Cites] J Bone Joint Surg Am. 1986 Oct;68(8):1197-205 [3021775.001]
  • [Cites] AJR Am J Roentgenol. 1995 Mar;164(3):573-80 [7863874.001]
  • [Cites] Ann Surg Oncol. 1997 Jul-Aug;4(5):425-31 [9259971.001]
  • [Cites] J Bone Joint Surg Am. 1996 May;78(5):656-63 [8642021.001]
  • [Cites] Am J Surg Pathol. 2000 Dec;24(12 ):1657-62 [11117787.001]
  • [Cites] Arch Pathol. 1973 May;95(5):336-40 [4694076.001]
  • [Cites] Radiographics. 2003 Sep-Oct;23 (5):1245-78 [12975513.001]
  • [Cites] Clin Orthop Relat Res. 2001 Jul;(388):252-7, 260-3 [11452971.001]
  • [Cites] Cancer. 1986 Jun 15;57(12 ):2444-53 [3697943.001]
  • [Cites] Cancer. 1959 Nov-Dec;12:1142-57 [14416919.001]
  • [Cites] Hum Pathol. 2003 Mar;34(3):263-9 [12673561.001]
  • [Cites] AJR Am J Roentgenol. 1998 Sep;171(3):759-62 [9725312.001]
  • [Cites] Eur J Radiol. 1995 Nov;21(1):34-40 [8654456.001]
  • (PMID = 16328381.001).
  • [ISSN] 0364-2348
  • [Journal-full-title] Skeletal radiology
  • [ISO-abbreviation] Skeletal Radiol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


29. Boeuf S, Kunz P, Hennig T, Lehner B, Hogendoorn P, Bovée J, Richter W: A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma. J Pathol; 2008 Oct;216(2):158-66
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma.
  • Phenotypic and molecular parallels between the development of chondrosarcoma and the differentiation of chondrocytes in normal growth plate suggest that chondrosarcoma may arise from mesenchymal precursor cells driven towards chondrogenesis.
  • We hypothesized that a comparison between cartilaginous tumours and their possible physiological cells of origin, mesenchymal stem cells (MSCs), might have biological and clinical relevance.
  • Gene expression profiles of chondrosarcoma were submitted to hierarchical clustering on the basis of these chondrogenesis-relevant genes.
  • This analysis allowed clear distinction between grade I and grade III chondrosarcoma and separated grade II chondrosarcoma into two groups.
  • This analysis shows that a molecular approach based on the comparison of tumour samples to an in vitro model for chondrogenic differentiation allows a new classification of chondrosarcoma in two clusters.
  • These data suggest that the identification of a pre-chondrogenic and a chondrogenic phenotype for chondrosarcoma by gene expression profiling could develop into a useful tool to predict the clinical behaviour of chondrosarcoma.
  • [MeSH-major] Chondrogenesis / genetics. Chondrosarcoma / genetics. Gene Expression Profiling. Gene Expression Regulation, Neoplastic. Mesenchymal Stromal Cells / physiology
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cell Differentiation. Cell Line, Tumor. Cluster Analysis. Female. Gene Expression. Genetic Markers. Humans. Male. Microarray Analysis. Middle Aged

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18702172.001).
  • [ISSN] 1096-9896
  • [Journal-full-title] The Journal of pathology
  • [ISO-abbreviation] J. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Genetic Markers
  •  go-up   go-down


30. Fanburg-Smith JC, Auerbach A, Marwaha JS, Wang Z, Rushing EJ: Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases. Hum Pathol; 2010 May;41(5):653-62
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
  • Mesenchymal chondrosarcoma, a rare malignant round cell and hyaline cartilage tumor, is most commonly intraosseous but can occur in extraskeletal sites.
  • We intensively observed the morphology and applied Sox9 (master regulator of chondrogenesis), beta-catenin (involved in bone formation, thought to inhibit chondrogenesis in a Sox9-dependent manner), and osteocalcin (a marker for osteoblastic phenotype) to 22 central nervous system and musculoskeletal mesenchymal chondrosarcoma.
  • Cases of mesenchymal chondrosarcoma were retrieved and reviewed from our files.
  • Immunohistochemistry and follow-up were obtained on mesenchymal chondrosarcoma and tumor controls.
  • Twenty-two mesenchymal chondrosarcomas included 5 central nervous system (all female; mean age, 30.2; mean size, 7.8 cm; in frontal lobe [n = 4] and spinal cord [n = 1]) and 17 musculoskeletal (female-male ratio, 11:6; mean age, 31.1; mean size, 6.2 cm; 3 each of humerus and vertebrae; 2 each of pelvis, rib, tibia, neck soft tissue; one each of femur, unspecified bone, and elbow soft tissue).
  • Small round cells of mesenchymal chondrosarcoma were negative for osteocalcin.
  • SOX9 was positive in both components of 21 of 22 cases of mesenchymal chondrosarcoma. beta-Catenin highlighted rare nuclei at the interface between round cells and hyaline cartilage in 35% cases.
  • Mesenchymal chondrosarcoma demonstrates centrally located hyaline cartilage with a linear progression of chondrocytes from resting to proliferative to hypertrophic, which undergoes endochondral ossification, recapitulating growth plate cartilage and suggesting that this component of mesenchymal chondrosarcoma may be a differentiated (benign or metaplastic) component of a malignant metastasizing tumor.
  • This hyaline cartilage component is morphologically different from cartilage of control chondrosarcoma.
  • Mesenchymal chondrosarcoma can be separated from small cell osteosarcoma, using Sox 9 for cartilage and osteocalcin for osteoblastic phenotype.
  • Rare nuclear beta-catenin expression at the interface between hyaline cartilage and small round cells potentially implicates the APC/Wnt pathway during endochondral ossification in morphologically benign hyaline cartilage component of mesenchymal chondrosarcoma.
  • [MeSH-major] Bone Neoplasms / pathology. Bone and Bones / pathology. Brain Neoplasms / pathology. Chondrosarcoma, Mesenchymal / pathology. Hyaline Cartilage / pathology. Osteocalcin / metabolism. SOX9 Transcription Factor / metabolism. beta Catenin / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Child. Chondrocytes / metabolism. Chondrocytes / pathology. Female. Humans. Immunohistochemistry. Male. Middle Aged. Ossification, Heterotopic / metabolism. Ossification, Heterotopic / pathology. Osteoblasts / metabolism. Osteoblasts / pathology

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • MedlinePlus Health Information. consumer health - Childhood Brain Tumors.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier Inc.
  • (PMID = 20138330.001).
  • [ISSN] 1532-8392
  • [Journal-full-title] Human pathology
  • [ISO-abbreviation] Hum. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / SOX9 Transcription Factor; 0 / SOX9 protein, human; 0 / beta Catenin; 104982-03-8 / Osteocalcin
  •  go-up   go-down


31. Huang J, Zhang HZ, Zheng L, Zhou J, Jiang ZM: [Clinicopathologic diagnosis of de-differentiated chondrosarcoma]. Zhonghua Bing Li Xue Za Zhi; 2009 Dec;38(12):820-3
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Clinicopathologic diagnosis of de-differentiated chondrosarcoma].
  • OBJECTIVE: To study the clinicopathologic and radiologic features of dedifferentiated chondrosarcoma, focusing on its diagnosis and differential diagnosis.
  • METHOD: Clinical, radiological and pathologic findings of 14 cases of dedifferentiated chondrosarcoma (including biopsy and surgical specimens) were analyzed by hematoxylin and eosin stained sections and immunohistochemistry.
  • The most common sites of involvement were pelvis, femur and humerus, similar to the conventional chondrosarcoma.
  • An essential histological feature of dedifferentiated chondrosarcoma was an abrupt interface between the low-grade cartilaginous tumor and high-grade anaplastic sarcoma.
  • CONCLUSIONS: Dedifferentiated chondrosarcoma is a rare subtype of chondrosarcoma with poor prognosis, which has different features of clinical manifestation, imaging features and pathological characteristics, compared to conventional chondrosarcoma and chondroblastic osteosarcoma.
  • [MeSH-major] Bone Neoplasms / pathology. Chondrosarcoma / pathology. Femoral Neoplasms / pathology. Humerus / pathology. Pelvic Bones / pathology
  • [MeSH-minor] Adult. Aged. Cell Differentiation. Chondrosarcoma, Mesenchymal / pathology. Diagnosis, Differential. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local. Osteosarcoma / pathology. Vimentin / metabolism. Young Adult

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20193457.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Vimentin
  •  go-up   go-down


32. Nonaka CF, de Aquino AR, de Almeida IC, de Souza LB, Pinto LC: Chondrosarcoma of the maxilla mimicking pulp disease on initial presentation. Quintessence Int; 2010 Nov-Dec;41(10):821-5
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chondrosarcoma of the maxilla mimicking pulp disease on initial presentation.
  • Chondrosarcomas are malignant mesenchymal tumors characterized by the differentiation of pure hyaline cartilage, and they are relatively uncommon in jawbones.
  • Chondrosarcoma of the jaws usually presents as a painless mass or swelling associated with loosening of the associated teeth.
  • This report describes an unusual case of chondrosarcoma that mimicked pulp disease on initial presentation in the maxilla of a 22-year-old man.
  • [MeSH-major] Chondrosarcoma / pathology. Dental Pulp Diseases / diagnosis. Maxillary Neoplasms / pathology
  • [MeSH-minor] Diagnosis, Differential. Humans. Male. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20927418.001).
  • [ISSN] 1936-7163
  • [Journal-full-title] Quintessence international (Berlin, Germany : 1985)
  • [ISO-abbreviation] Quintessence Int
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Germany
  •  go-up   go-down


33. Misra V, Singh PA: Cytodiagnosis of extraosseous mesenchymal chondrosarcoma of meninges: a case report. Acta Cytol; 2008 May-Jun;52(3):366-8
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Cytodiagnosis of extraosseous mesenchymal chondrosarcoma of meninges: a case report.
  • BACKGROUND: Extraosseous mesenchymal chondrosarcoma (MC) is a rare neoplasm.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Cytodiagnosis. Meningeal Neoplasms / pathology
  • [MeSH-minor] Adult. Antigens, CD / metabolism. Biopsy, Fine-Needle. Diagnosis, Differential. Female. Humans. S100 Proteins / metabolism

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18540308.001).
  • [ISSN] 0001-5547
  • [Journal-full-title] Acta cytologica
  • [ISO-abbreviation] Acta Cytol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / S100 Proteins
  •  go-up   go-down


34. Lloret I, Server A, Bjerkehagen B: Primary spinal chondrosarcoma: radiologic findings with pathologic correlation. Acta Radiol; 2006 Feb;47(1):77-84
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary spinal chondrosarcoma: radiologic findings with pathologic correlation.
  • PURPOSE: To describe the radiologic appearance of the four types of primary spinal chondrosarcoma (CHS) (conventional intramedullary, juxtacortical, clear cell, and mesenchymal) and to correlate with histopathologic findings.
  • While the clear cell and mesenchymal types show some distinctive features, these do not allow confident radiologic diagnosis.
  • [MeSH-major] Chondrosarcoma / diagnosis. Chondrosarcoma / pathology. Spinal Neoplasms / diagnosis. Spinal Neoplasms / pathology. Spine / pathology. Spine / radiography
  • [MeSH-minor] Adult. Aged. Cervical Vertebrae / pathology. Female. Follow-Up Studies. Humans. Lumbar Vertebrae / pathology. Magnetic Resonance Imaging / methods. Male. Middle Aged. Retrospective Studies. Thoracic Vertebrae / pathology. Tomography, X-Ray Computed / methods

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16498937.001).
  • [ISSN] 0284-1851
  • [Journal-full-title] Acta radiologica (Stockholm, Sweden : 1987)
  • [ISO-abbreviation] Acta Radiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Sweden
  •  go-up   go-down


35. Dantonello TM, Int-Veen C, Leuschner I, Schuck A, Furtwaengler R, Claviez A, Schneider DT, Klingebiel T, Bielack SS, Koscielniak E, CWS study group, COSS study group: Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups. Cancer; 2008 Jun;112(11):2424-31
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma of soft tissues and bone in children, adolescents, and young adults: experiences of the CWS and COSS study groups.
  • BACKGROUND: Mesenchymal chondrosarcoma (MCS) is a rare tumor with a strong tendency toward late recurrences leading to reported 10-year survival rates below 50%.
  • [MeSH-major] Bone Neoplasms / pathology. Chondrosarcoma, Mesenchymal / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Antineoplastic Combined Chemotherapy Protocols / therapeutic use. Child. Child, Preschool. Combined Modality Therapy. Female. Follow-Up Studies. Humans. Infant. Male. Neoplasm Staging. Prospective Studies. Radiotherapy Dosage. Survival Rate. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2008 American Cancer Society.
  • (PMID = 18438777.001).
  • [ISSN] 1097-0142
  • [Journal-full-title] Cancer
  • [ISO-abbreviation] Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


36. Lee SY, Lim YC, Song MH, Seok JY, Lee WS, Choi EC: Chondrosarcoma of the head and neck. Yonsei Med J; 2005 Apr 30;46(2):228-32
MedlinePlus Health Information. consumer health - Head and Neck Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chondrosarcoma of the head and neck.
  • Chondrosarcoma of the head and neck region is a rare disease, representing approximately 0.1% of all head and neck neoplasms.
  • The 5-year survival rate of chondrosarcoma is 70-80%, showing relatively good prognosis; however, it is known to progress slowly and eventually cause multiple metastases.
  • In this study, we reviewed chondrosarcoma cases experienced at Yonsei University Medical College during the last 15 years to investigate its clinical characteristics and treatment outcome.
  • The medical records of 8 patients who were diagnosed with chondrosarcoma of the head and neck region and underwent surgical treatment between December 1990 and December 2002 were retrospectively reviewed.
  • The pathological findings showed chondrosarcoma in 7 cases and mesenchymal chondrosarcoma in 1 case.
  • [MeSH-major] Chondrosarcoma / complications. Chondrosarcoma / surgery. Head and Neck Neoplasms / complications. Head and Neck Neoplasms / surgery
  • [MeSH-minor] Adult. Female. Humans. Incidence. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Radiotherapy, Adjuvant. Retrospective Studies. Survival Analysis. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Head Neck. 2000 Jul;22(4):408-25 [10862026.001]
  • [Cites] J Surg Oncol. 1997 Aug;65(4):269-73 [9274792.001]
  • [Cites] Am J Surg. 1970 Oct;120(4):456-60 [5507330.001]
  • [Cites] Cancer. 1974 Aug;34(2):453-63 [4853358.001]
  • [Cites] Cancer. 1977 Aug;40(2):818-31 [890662.001]
  • [Cites] Cancer. 1980 Jun 1;45(11):2769-77 [7379008.001]
  • [Cites] Head Neck Surg. 1980 Sep-Oct;3(1):43-57 [6250996.001]
  • [Cites] Arch Otolaryngol. 1981 Feb;107(2):125-7 [7469892.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1982 Feb;8(2):187-90 [6806219.001]
  • [Cites] Am J Surg Pathol. 1984 Mar;8(3):223-30 [6703199.001]
  • [Cites] Laryngoscope. 1984 Dec;94(12 Pt 1):1539-44 [6503573.001]
  • [Cites] J Otolaryngol. 1984 Dec;13(6):391-4 [6100552.001]
  • [Cites] J Oral Maxillofac Surg. 1986 Jan;44(1):73-9 [3455727.001]
  • [Cites] Am J Surg Pathol. 1987 Dec;11(12):930-42 [3688300.001]
  • [Cites] J Oral Pathol. 1988 Jan;17(1):1-11 [3131504.001]
  • [Cites] Laryngoscope. 1990 Dec;100(12):1301-5 [2243522.001]
  • [Cites] World J Surg. 1992 Sep-Oct;16(5):1010-5; discussion 1015-6 [1462610.001]
  • [Cites] Hum Pathol. 1995 Nov;26(11):1215-20 [7590695.001]
  • [Cites] Ann Otol Rhinol Laryngol. 1997 Feb;106(2):94-100 [9041812.001]
  • [Cites] J Bone Joint Surg Br. 1966 Nov;48(4):729-64 [5333450.001]
  • (PMID = 15861495.001).
  • [ISSN] 0513-5796
  • [Journal-full-title] Yonsei medical journal
  • [ISO-abbreviation] Yonsei Med. J.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Other-IDs] NLM/ PMC2823018
  •  go-up   go-down


37. Fanburg-Smith JC, Auerbach A, Marwaha JS, Wang Z, Santi M, Judkins AR, Rushing EJ: Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases. Ann Diagn Pathol; 2010 Feb;14(1):8-14
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Immunoprofile of mesenchymal chondrosarcoma: aberrant desmin and EMA expression, retention of INI1, and negative estrogen receptor in 22 female-predominant central nervous system and musculoskeletal cases.
  • Mesenchymal chondrosarcoma is a rare malignant tumor in the differential diagnosis of other small, round blue cell tumors, including atypical teratoid tumor in the central nervous system (CNS) and rhabdomyosarcoma in the musculoskeletal (MSK) locations.
  • The CNS and MSK mesenchymal chondrosarcoma predominantly affects adult females with poor prognosis.
  • By immunohistochemistry, mesenchymal chondrosarcoma occasionally expresses aberrant desmin and EMA but is negative for SMA, myogenin MyoD1, GFAP, and keratins, refuting true smooth or skeletal muscle, epithelial, or meningothelial phenotype.
  • Despite marked female predominance in our series, estrogen receptor is negative in mesenchymal chondrosarcoma.
  • [MeSH-major] Bone Neoplasms / pathology. Chondrosarcoma, Mesenchymal / pathology. Chromosomal Proteins, Non-Histone / metabolism. DNA-Binding Proteins / metabolism. Desmin / metabolism. Mucin-1 / metabolism. Nervous System Neoplasms / pathology. Receptors, Estrogen / metabolism. Transcription Factors / metabolism
  • [MeSH-minor] Adolescent. Adult. Aged. Biomarkers, Tumor / metabolism. Child. Female. Follow-Up Studies. Humans. Immunohistochemistry. Male. Middle Aged. Young Adult

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier Inc.
  • (PMID = 20123451.001).
  • [ISSN] 1532-8198
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Chromosomal Proteins, Non-Histone; 0 / DNA-Binding Proteins; 0 / Desmin; 0 / Mucin-1; 0 / Receptors, Estrogen; 0 / SMARCB1 protein, human; 0 / Transcription Factors
  •  go-up   go-down


38. Matsuda Y, Sakayama K, Sugawara Y, Miyawaki J, Kidani T, Miyazaki T, Tanji N, Yamamoto H: Mesenchymal chondrosarcoma treated with total en bloc spondylectomy for 2 consecutive lumbar vertebrae resulted in continuous disease-free survival for more than 5 years: case report. Spine (Phila Pa 1976); 2006 Apr 15;31(8):E231-6
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma treated with total en bloc spondylectomy for 2 consecutive lumbar vertebrae resulted in continuous disease-free survival for more than 5 years: case report.
  • SUMMARY OF BACKGROUND DATA: Primary mesenchymal chondrosarcoma in the spine is extremely rare.
  • The patient was diagnosed as having chondrosarcoma based on biopsy findings.
  • However, the postoperative pathologic diagnosis was extremely difficult because the patient was initially suspected to have osteosarcoma, but the final diagnosis was mesenchymal chondrosarcoma.
  • CONCLUSIONS: To our knowledge, we reported the first case of mesenchymal chondrosarcoma occurring from the lumbar spine treated with total en bloc spondylectomy and chemotherapy.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / surgery. Lumbar Vertebrae / surgery. Spinal Neoplasms / surgery
  • [MeSH-minor] Adult. Antineoplastic Agents / therapeutic use. Disease-Free Survival. Female. Humans

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16622368.001).
  • [ISSN] 1528-1159
  • [Journal-full-title] Spine
  • [ISO-abbreviation] Spine
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antineoplastic Agents
  •  go-up   go-down


39. Sopta J, Dordević A, Tulić G, Mijucić V: Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases. J Cancer Res Clin Oncol; 2008 Feb;134(2):147-52
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dedifferentiated chondrosarcoma: our clinico-pathological experience and dilemmas in 25 cases.
  • BACKGROUND: Dedifferentiated chondrosarcoma represents a special form of the chondrosarcoma characterized by the presence of well-differentiated cartilaginous component in juxtaposition with the malignant mesenchymal tumor of high-malignancy grade.
  • [MeSH-major] Bone Neoplasms / pathology. Cell Differentiation. Chondrosarcoma / pathology
  • [MeSH-minor] Adult. Aged. Biomarkers, Tumor / metabolism. Female. Fibrosarcoma / diagnostic imaging. Fibrosarcoma / pathology. Fibrosarcoma / surgery. Humans. Immunoenzyme Techniques. Male. Middle Aged. Osteosarcoma / diagnostic imaging. Osteosarcoma / pathology. Osteosarcoma / surgery. Prognosis. Radiography. Rhabdomyosarcoma / diagnostic imaging. Rhabdomyosarcoma / pathology. Rhabdomyosarcoma / surgery

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Bone Joint Surg Am. 2001 Nov;83-A(11):1630-42 [11701784.001]
  • [Cites] Cancer. 2006 Jun 15;106(12 ):2682-91 [16691621.001]
  • [Cites] Lancet Oncol. 2005 Aug;6(8):599-607 [16054571.001]
  • [Cites] Virchows Arch. 2002 Sep;441(3):219-30 [12242518.001]
  • [Cites] Folia Morphol (Warsz). 2003 Nov;62(4):513-5 [14655155.001]
  • [Cites] Mod Pathol. 2001 Apr;14(4):343-9 [11301351.001]
  • [Cites] Pathol Res Pract. 2003;199(6):437-44 [12924447.001]
  • [Cites] J Cancer Res Clin Oncol. 2005 Jun;131(6):333-9 [15785935.001]
  • [Cites] J Bone Joint Surg Am. 2004 Nov;86-A(11):2412-8 [15523011.001]
  • [Cites] Clin Radiol. 2004 Mar;59(3):268-72 [15037140.001]
  • [Cites] Cesk Patol. 2003 Apr;39(2):59-63 [12874902.001]
  • [Cites] Cancer Genet Cytogenet. 2003 Jul 1;144(1):61-4 [12810257.001]
  • [Cites] Ann Diagn Pathol. 2002 Jun;6(3):159-63 [12089726.001]
  • [Cites] Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Mar;97(3):369-75 [15024362.001]
  • [Cites] Virchows Arch A Pathol Anat Histopathol. 1987;411(1):23-32 [2437690.001]
  • (PMID = 17653766.001).
  • [ISSN] 1432-1335
  • [Journal-full-title] Journal of cancer research and clinical oncology
  • [ISO-abbreviation] J. Cancer Res. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  •  go-up   go-down


40. Guo W, Li D, Tang X, Ji T: Surgical treatment of pelvic chondrosarcoma involving periacetabulum. J Surg Oncol; 2010 Feb 1;101(2):160-5
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Surgical treatment of pelvic chondrosarcoma involving periacetabulum.
  • BACKGROUND AND OBJECTIVES: Surgical treatment of pelvic chondrosarcoma involving acetabulum is challenging.
  • There were 32 patients with conventional chondrosarcomas, 9 with dedifferentiated chondrosarcomas, and 4 with mesenchymal chondrosarcomas.
  • [MeSH-major] Acetabulum / surgery. Bone Neoplasms / surgery. Chondrosarcoma / surgery. Neoplasm Recurrence, Local
  • [MeSH-minor] Adolescent. Adult. Female. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19960486.001).
  • [ISSN] 1096-9098
  • [Journal-full-title] Journal of surgical oncology
  • [ISO-abbreviation] J Surg Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


41. Kotil K, Bilge T, Olagac V: Primary intradural myxoid chondrosarcoma: a case report and review in the literature. J Neurooncol; 2005 Nov;75(2):169-72
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary intradural myxoid chondrosarcoma: a case report and review in the literature.
  • Therapeutic experience with primary spinal mesenchymal chondrosarcomas is also extremely limited.
  • We report the first case in the literature of a primary intradural myxoid chondrosarcoma.
  • We could not identify this lesion as chondrosarcoma in preoperative period.
  • The mass was excised completely and microscopic examination identified a myxomatous chondrosarcoma.
  • But a histological examination revealed primary myxoid chondrosarcoma.
  • Experience with primary spinal mesenchymal chondrosarcomas is also extremely limited.
  • This case presents the first case in the literature of an primary spinal intradural myxoid chondrosarcoma.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Meningeal Neoplasms / diagnosis. Meningeal Neoplasms / pathology. Pia Mater / pathology
  • [MeSH-minor] Adult. Dura Mater / surgery. Follow-Up Studies. Humans. Magnetic Resonance Imaging. Male. Time Factors. Treatment Outcome. X-Rays

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16283441.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Netherlands
  • [Number-of-references] 12
  •  go-up   go-down


42. Diaz-Romero J, Romeo S, Bovée JV, Hogendoorn PC, Heini PF, Mainil-Varlet P: Hierarchical clustering of flow cytometry data for the study of conventional central chondrosarcoma. J Cell Physiol; 2010 Nov;225(2):601-11
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Hierarchical clustering of flow cytometry data for the study of conventional central chondrosarcoma.
  • We have investigated the use of hierarchical clustering of flow cytometry data to classify samples of conventional central chondrosarcoma, a malignant cartilage forming tumor of uncertain cellular origin, according to similarities with surface marker profiles of several known cell types.
  • Human primary chondrosarcoma cells, articular chondrocytes, mesenchymal stem cells, fibroblasts, and a panel of tumor cell lines from chondrocytic or epithelial origin were clustered based on the expression profile of eleven surface markers.
  • By selecting clustering approaches shown to give reproducible results for cluster recovery of known cell types, primary conventional central chondrosacoma cells could be grouped in two main clusters with distinctive marker expression signatures: one group clustering together with mesenchymal stem cells (CD49b-high/CD10-low/CD221-high) and a second group clustering close to fibroblasts (CD49b-low/CD10-high/CD221-low).
  • Hierarchical clustering also revealed substantial differences between primary conventional central chondrosarcoma cells and established chondrosarcoma cell lines, with the latter not only segregating apart from primary tumor cells and normal tissue cells, but clustering together with cell lines from epithelial lineage.
  • [MeSH-major] Biomarkers, Tumor / metabolism. Bone Neoplasms / classification. Chondrosarcoma / classification. Flow Cytometry. Gene Expression Profiling. Gene Expression Regulation, Neoplastic / physiology
  • [MeSH-minor] Adult. Aged. Algorithms. Cell Line, Tumor. Chondrocytes / metabolism. Cluster Analysis. Female. Humans. Male. Middle Aged. Neoplasm Proteins / genetics. Neoplasm Proteins / metabolism

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] (c) 2010 Wiley-Liss, Inc.
  • (PMID = 20506378.001).
  • [ISSN] 1097-4652
  • [Journal-full-title] Journal of cellular physiology
  • [ISO-abbreviation] J. Cell. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / Neoplasm Proteins
  •  go-up   go-down


43. Damron TA, Ward WG, Stewart A: Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res; 2007 Jun;459:40-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report.
  • We summarize descriptive epidemiologic and survival data from the National Cancer Data Base of the American College of Surgeons for 26,437 cases of osteosarcoma (n = 11,961), chondrosarcoma (n = 9606), and Ewing's sarcoma (n = 4870) from 1985 to 2003.
  • The relative 5-year survival rate was 53.9% for osteosarcoma, 75.2% for chondrosarcoma, and 50.6% for Ewing's sarcoma.
  • Within chondrosarcomas, the relative 5-year survival rate was 76% for conventional, 71% for myxoid, 87% for juxtacortical, and 52% for mesenchymal.
  • [MeSH-major] Bone Neoplasms / epidemiology. Chondrosarcoma / epidemiology. Osteosarcoma / epidemiology. Sarcoma, Ewing / epidemiology
  • [MeSH-minor] Adolescent. Adult. Age Distribution. Aged. Aged, 80 and over. Child. Databases, Factual. Humans. Middle Aged. Sex Distribution. Survival Rate. United States / epidemiology


44. Hong P, Taylor SM, Trites JR, Bullock M, Nasser JG, Hart RD: Chondrosarcoma of the head and neck: report of 11 cases and literature review. J Otolaryngol Head Neck Surg; 2009 Apr;38(2):279-85
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chondrosarcoma of the head and neck: report of 11 cases and literature review.
  • OBJECTIVE: Chondrosarcoma is a malignant tumour of mesenchymal origin.
  • METHODS: Eleven chondrosarcoma cases of the head and neck were retrospectively identified at a tertiary care teaching centre.
  • [MeSH-major] Chondrosarcoma / pathology. Head and Neck Neoplasms / pathology
  • [MeSH-minor] Adolescent. Adult. Aged. Combined Modality Therapy. Disease Progression. Female. Humans. Laryngectomy. Male. Middle Aged. Prognosis. Retrospective Studies. Young Adult

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Head and Neck Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19442379.001).
  • [ISSN] 1916-0216
  • [Journal-full-title] Journal of otolaryngology - head & neck surgery = Le Journal d'oto-rhino-laryngologie et de chirurgie cervico-faciale
  • [ISO-abbreviation] J Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Canada
  • [Number-of-references] 35
  •  go-up   go-down


45. Hameetman L, Kok P, Eilers PH, Cleton-Jansen AM, Hogendoorn PC, Bovée JV: The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting. Virchows Arch; 2005 Apr;446(4):430-7
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting.
  • Distinguishing osteochondroma from low-grade secondary peripheral chondrosarcoma can be difficult.
  • A previous pilot study focusing on expression of putative EXT downstream effectors indicated that progression of osteochondroma towards grade I chondrosarcoma was characterised by upregulation of Bcl-2 and parathyroid hormone-like hormone (PTHLH).
  • Thus, in cases where the distinction between osteochondroma and chondrosarcoma is difficult, Bcl-2 is a valuable diagnostic marker for malignancy, regardless of tumour size, patient gender or age, and this can be extended with PTHLH for non-adolescent male patients.
  • [MeSH-major] Bone Neoplasms / pathology. Chondrosarcoma, Mesenchymal / pathology. Osteochondroma / pathology. Parathyroid Hormone-Related Protein / metabolism. Proto-Oncogene Proteins c-bcl-2 / metabolism
  • [MeSH-minor] Adolescent. Adult. Age Factors. Aged. Aged, 80 and over. Biomarkers, Tumor / metabolism. Child. Child, Preschool. Diagnosis, Differential. Female. Humans. Immunohistochemistry. In Situ Hybridization. Male. Middle Aged. RNA, Messenger / metabolism. Sensitivity and Specificity. Sex Factors

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1977 Aug;40(2):818-31 [890662.001]
  • [Cites] Oncogene. 1998 Sep 10;17(10):1235-43 [9771966.001]
  • [Cites] J Cell Biochem. 2003 Jan 1;88(1):128-37 [12461782.001]
  • [Cites] Science. 1996 Aug 2;273(5275):663-6 [8662561.001]
  • [Cites] Nat Genet. 1995 Oct;11(2):137-43 [7550340.001]
  • [Cites] Am J Respir Crit Care Med. 1998 Dec;158(6):1951-7 [9847291.001]
  • [Cites] Br J Cancer. 2003 Jul 7;89(1):55-64 [12838300.001]
  • [Cites] Am J Hum Genet. 1999 Sep;65(3):689-98 [10441575.001]
  • [Cites] Clin Orthop Relat Res. 1985 Dec;(201):214-37 [4064409.001]
  • [Cites] Genes Chromosomes Cancer. 1999 Nov;26(3):237-46 [10502322.001]
  • [Cites] J Pediatr Endocrinol Metab. 2001;14 Suppl 6:1527-33 [11837510.001]
  • [Cites] Clin Orthop Relat Res. 2002 Oct;(403):198-204 [12360027.001]
  • [Cites] Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):73-83 [10477009.001]
  • [Cites] J Pathol. 1998 Jan;184(1):24-30 [9582523.001]
  • [Cites] J Bone Miner Res. 2000 Jun;15(6):1045-55 [10841173.001]
  • [Cites] Radiology. 2000 Feb;214(2):539-46 [10671608.001]
  • [Cites] Nat Genet. 1996 Sep;14(1):25-32 [8782816.001]
  • [Cites] Hum Mol Genet. 1996 Oct;5(10):1547-57 [8894688.001]
  • [Cites] Bone. 2002 Mar;30(3):478-85 [11882461.001]
  • [Cites] J Bone Miner Res. 1999 Apr;14(4):475-82 [10234567.001]
  • [Cites] Clin Sci (Lond). 2000 Feb;98(2):217-40 [10657279.001]
  • [Cites] Pathology. 2002 Apr;34(2):133-7 [12009094.001]
  • [Cites] Verh Dtsch Ges Pathol. 1998;82:160-9 [10095428.001]
  • [Cites] Lab Invest. 2000 Dec;80(12):1925-34 [11140704.001]
  • [Cites] J Cell Biol. 1997 Jan 13;136(1):205-13 [9008714.001]
  • [Cites] Hum Mol Genet. 1999 Nov;8(12):2155-64 [10545594.001]
  • [Cites] J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):259-65 [7626465.001]
  • [Cites] Stat Med. 1998 Jan 15;17(1):59-68 [9463849.001]
  • (PMID = 15744499.001).
  • [ISSN] 0945-6317
  • [Journal-full-title] Virchows Archiv : an international journal of pathology
  • [ISO-abbreviation] Virchows Arch.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Biomarkers, Tumor; 0 / PTHLH protein, human; 0 / Parathyroid Hormone-Related Protein; 0 / Proto-Oncogene Proteins c-bcl-2; 0 / RNA, Messenger
  •  go-up   go-down


46. Chi YK, Shen Q, Wang JC, Zheng XZ, Hou L, Zhang B: [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas]. Beijing Da Xue Xue Bao; 2008 Aug 18;40(4):363-8
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Correlation of telomere length and the expression of its regulating proteins in mesenchymal sarcomas].
  • OBJECTIVE: To explore the significance in the change of telomere length in mesenchymal sarcomas, through analyzing telomere length and expression of its associated proteins, including TRF1, POT1, hTERT, P53 and c-myc.
  • Similarly, the telomere length of rhabdomyosarcoma was shorter than that of chondrosarcoma (P<0.05).
  • CONCLUSION: The shortening of telomere could prevail in mesenchymal sarcoma and reflect the malignant potential.
  • [MeSH-minor] Adult. Chondrosarcoma / genetics. Chondrosarcoma / metabolism. Female. Humans. In Situ Hybridization, Fluorescence / methods. Liposarcoma / genetics. Liposarcoma / metabolism. Male. Middle Aged. Proto-Oncogene Proteins c-myc / genetics. Proto-Oncogene Proteins c-myc / metabolism. Rhabdomyosarcoma / genetics. Rhabdomyosarcoma / metabolism. Telomerase / genetics. Telomerase / metabolism. Telomeric Repeat Binding Protein 1 / genetics. Telomeric Repeat Binding Protein 1 / metabolism. Tumor Suppressor Protein p53 / genetics. Tumor Suppressor Protein p53 / metabolism

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18677381.001).
  • [ISSN] 1671-167X
  • [Journal-full-title] Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences
  • [ISO-abbreviation] Beijing Da Xue Xue Bao
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] China
  • [Chemical-registry-number] 0 / POT1 protein, human; 0 / Proto-Oncogene Proteins c-myc; 0 / TP53 protein, human; 0 / Telomere-Binding Proteins; 0 / Telomeric Repeat Binding Protein 1; 0 / Tumor Suppressor Protein p53; EC 2.7.7.49 / TERT protein, human; EC 2.7.7.49 / Telomerase
  •  go-up   go-down


47. Chatzipantelis P, Karvouni E, Fragoulidis GP, Voros D, Pafiti A: Clinicopathologic features of two rare cases of mesenchymal metastatic tumors in the pancreas: review of the literature. Pancreas; 2006 Oct;33(3):301-3
MedlinePlus Health Information. consumer health - Pancreatic Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinicopathologic features of two rare cases of mesenchymal metastatic tumors in the pancreas: review of the literature.
  • OBJECTIVES: A clinicopathologic presentation of 2 unusual cases of metastatic mesenchymal neoplasms in the pancreas.
  • METHODS: The first case concerns a 26-year-old man with a history of intracranial mesenchymal chondrosarcoma (since the age of 17), 2 left lung operations, and 3 right thigh operations.
  • RESULTS: In the first case, the pathological examination revealed a tumor measuring 3.8 x 3.5 cm and histologically compatible with mesenchymal chondrosarcoma, developing in a vessel lumen and invading into the pancreatic parenchyma.
  • CONCLUSIONS: The cases of metastatic uterus leiomyosarcoma and the metastatic intracranial chondrosarcoma are, to our knowledge, the first to be described.
  • [MeSH-minor] Adenocarcinoma / pathology. Adult. Aged. Chondrosarcoma / pathology. Diagnosis, Differential. Female. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17003653.001).
  • [ISSN] 1536-4828
  • [Journal-full-title] Pancreas
  • [ISO-abbreviation] Pancreas
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


48. Papachristou DJ, Goodman MA, Cieply K, Hunt JL, Rao UN: Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis. Hum Pathol; 2006 Jul;37(7):890-8
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Comparison of allelic losses in chondroblastoma and primary chondrosarcoma of bone and correlation with fluorescence in situ hybridization analysis.
  • The selected chromosomes are known to be involved in several mesenchymal neoplasms.
  • [MeSH-major] Bone Neoplasms / genetics. Chondroblastoma / genetics. Chondrosarcoma / genetics. In Situ Hybridization, Fluorescence. Loss of Heterozygosity
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Polymerase Chain Reaction


49. Koriyama N, Nishimoto K, Kodama T, Nakazaki M, Kurono Y, Yoshida H, Tei C: Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor. Am J Med Sci; 2006 Sep;332(3):142-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Oncogenic osteomalacia in a case with a maxillary sinus mesenchymal tumor.
  • The pathologic diagnosis of the tumor was a "phosphaturic mesenchymal tumor, mixed with a connective tissue variant."
  • [MeSH-major] Chondrosarcoma, Mesenchymal / complications. Maxillary Sinus Neoplasms / complications. Osteomalacia / etiology
  • [MeSH-minor] Adult. Female. Humans. Time Factors

  • Genetic Alliance. consumer health - Oncogenic osteomalacia.
  • Genetic Alliance. consumer health - Osteomalacia.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16969146.001).
  • [ISSN] 0002-9629
  • [Journal-full-title] The American journal of the medical sciences
  • [ISO-abbreviation] Am. J. Med. Sci.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


50. Kim SG, Jeon CH, Suh HS, Choe JY, Shin IH: P-glycoprotein expression in extracellular matrix formation of chondrogenic differentiation of human adult stem cells. Cell Biol Int; 2007 Sep;31(9):1042-8

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] P-glycoprotein expression in extracellular matrix formation of chondrogenic differentiation of human adult stem cells.
  • Mesenchymal stem cell (MSC) has been known as a good source of progenitor for multiple connective tissue including cartilage, muscle, adipocyte, and bone.
  • P-gp expression has been reported in chondrosarcoma and hypertrophic chondrocyte in the human growth plate.
  • This study was designed to investigate the expression of P-gp during chondrogenic differentiation of adult human stem cells.
  • [MeSH-major] Adult Stem Cells / cytology. Adult Stem Cells / metabolism. Cell Differentiation. Chondrogenesis. Extracellular Matrix / metabolism. P-Glycoprotein / genetics. P-Glycoprotein / metabolism
  • [MeSH-minor] Bone Marrow Cells / cytology. Cell Separation. Cell Survival. Cells, Cultured. Collagen Type II / genetics. Collagen Type II / metabolism. Flow Cytometry. Gene Expression Regulation. Glycosaminoglycans / metabolism. Humans. Mesenchymal Stromal Cells / cytology

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17468018.001).
  • [ISSN] 1065-6995
  • [Journal-full-title] Cell biology international
  • [ISO-abbreviation] Cell Biol. Int.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Collagen Type II; 0 / Glycosaminoglycans; 0 / P-Glycoprotein
  •  go-up   go-down


51. Dornauer K, Söder S, Inwards CY, Bovee JV, Aigner T: Matrix biochemistry and cell biology of dedifferentiated chondrosarcomas. Pathol Int; 2010 May;60(5):365-72
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Dedifferentiated chondrosarcoma is an uncommon mesenchymal neoplasm comprised of two different components, low-grade conventional chondrosarcoma and high-grade non-cartilaginous sarcoma.
  • Our results lend further support to the notion that dedifferentiated chondrosarcoma represents transdifferentiation of a cell towards various blastic mesenchymal cell lineages, most commonly osteoblastic and fibroblastic, but occasionally chondroblastic as well.
  • [MeSH-major] Bone Neoplasms / metabolism. Chondrosarcoma / metabolism. Extracellular Matrix / metabolism. Extracellular Matrix Proteins / metabolism
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Cell Dedifferentiation. Collagen Type III / metabolism. Collagen Type VI / metabolism. Female. Fluorescent Antibody Technique, Direct. Glycosaminoglycans / metabolism. Humans. Male. Middle Aged. Prognosis

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20518886.001).
  • [ISSN] 1440-1827
  • [Journal-full-title] Pathology international
  • [ISO-abbreviation] Pathol. Int.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Australia
  • [Chemical-registry-number] 0 / Collagen Type III; 0 / Collagen Type VI; 0 / Extracellular Matrix Proteins; 0 / Glycosaminoglycans
  •  go-up   go-down


52. Higuchi T, Taki J, Sumiya H, Kinuya S, Nakajima K, Namura M, Tonami N: Characterization of cartilaginous tumors with 201Tl scintigraphy. Ann Nucl Med; 2005 Apr;19(2):95-9
Hazardous Substances Data Bank. THALLOUS CHLORIDE .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Twenty-two cases with histologically proven cartilaginous tumors (3 enchondromas, 15 conventional chondrosarcomas (grade I = 9, II = 5, III = 1), 3 mesenchymal chondrosarcomas, and 1 de-differentiated chondrosarcoma) were examined retrospectively.
  • 201Tl uptake scores were 1 among 1 of 5 grades II and a grade III conventional chondrosarcoma.
  • Mesenchymal chondrosarcoma and de-differentiated chondrosarcoma displayed 201Tl uptake scores of 2 or 3.
  • CONCLUSIONS: Absence of elevated 201Tl uptake in cartilaginous tumors was indicative of enchondroma or low-grade conventional chondrosarcoma.
  • However, in instances in which 201Tl uptake is obvious, high-grade chondrosarcoma or variant types should be considered.
  • [MeSH-minor] Adult. Aged. Aged, 80 and over. Chondroma / metabolism. Chondroma / radionuclide imaging. Chondrosarcoma / metabolism. Chondrosarcoma / radionuclide imaging. Female. Humans. Male. Middle Aged. Neoplasm Staging / methods. Radiopharmaceuticals / pharmacokinetics. Reproducibility of Results. Retrospective Studies. Sensitivity and Specificity. Statistics as Topic

  • Hazardous Substances Data Bank. THALLIUM, ELEMENTAL .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15909488.001).
  • [ISSN] 0914-7187
  • [Journal-full-title] Annals of nuclear medicine
  • [ISO-abbreviation] Ann Nucl Med
  • [Language] eng
  • [Publication-type] Evaluation Studies; Journal Article; Validation Studies
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 7791-12-0 / thallium chloride; AD84R52XLF / Thallium
  •  go-up   go-down


53. Förander P, Rähn T, Kihlström L, Ulfarsson E, Mathiesen T: Combination of microsurgery and Gamma Knife surgery for the treatment of intracranial chondrosarcomas. J Neurosurg; 2006 Dec;105 Suppl:18-25

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This retrospective study of patients with intracranial chondrosarcoma was conducted to determine the long-term results of microsurgery followed by Gamma Knife surgery (GKS) for residual tumor or recurrence.
  • Seven patients had low-grade chondrosarcomas (LGCSs), whereas mesenchymal chondrosarcomas (MCSs) were diagnosed in two.
  • Similar to other treatments for intracranial chondrosarcoma, morbidity after micro- and radiosurgical combination therapy was high and included severe cranial nerve palsies.
  • [MeSH-major] Chondrosarcoma / surgery. Microsurgery. Radiosurgery. Skull Base Neoplasms / surgery
  • [MeSH-minor] Adult. Cohort Studies. Combined Modality Therapy. Disease-Free Survival. Female. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18503325.001).
  • [ISSN] 0022-3085
  • [Journal-full-title] Journal of neurosurgery
  • [ISO-abbreviation] J. Neurosurg.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


54. Hameed M: Small round cell tumors of bone. Arch Pathol Lab Med; 2007 Feb;131(2):192-204
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • They include Ewing sarcoma/peripheral neuroectodermal tumor or Ewing family tumors, lymphoma, mesenchymal chondrosarcoma, and small cell osteosarcoma.
  • [MeSH-minor] Adolescent. Adult. Child. Chondrosarcoma / genetics. Chondrosarcoma / pathology. Chondrosarcoma / therapy. Humans. Immunohistochemistry. Neuroectodermal Tumors, Primitive / genetics. Neuroectodermal Tumors, Primitive / pathology. Neuroectodermal Tumors, Primitive / therapy. Osteosarcoma / genetics. Osteosarcoma / pathology. Osteosarcoma / therapy. Prognosis. Sarcoma, Ewing / genetics. Sarcoma, Ewing / pathology. Sarcoma, Ewing / therapy. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17284103.001).
  • [ISSN] 1543-2165
  • [Journal-full-title] Archives of pathology & laboratory medicine
  • [ISO-abbreviation] Arch. Pathol. Lab. Med.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 133
  •  go-up   go-down


55. Damm DD: Maxillary radiolucency. Mesenchymal chondrosarcoma. Gen Dent; 2009 Sep-Oct;57(5):528, 531
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Maxillary radiolucency. Mesenchymal chondrosarcoma.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Maxillary Neoplasms / diagnosis
  • [MeSH-minor] Biopsy. Biopsy, Needle. Diagnosis, Differential. Humans. Male. Radiography, Panoramic. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19903647.001).
  • [ISSN] 0363-6771
  • [Journal-full-title] General dentistry
  • [ISO-abbreviation] Gen Dent
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


56. Stenstam BH, Pellettieri L, Sorteberg W, Rezaei A, Sköld K: BNCT for recurrent intracranial meningeal tumours - case reports. Acta Neurol Scand; 2007 Apr;115(4):243-7
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [MeSH-major] Boron Neutron Capture Therapy. Brain Neoplasms / radiotherapy. Chondrosarcoma, Mesenchymal / radiotherapy. Meningeal Neoplasms / radiotherapy. Meningioma / radiotherapy. Neoplasm Recurrence, Local / radiotherapy
  • [MeSH-minor] Adult. Aged. Female. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17376121.001).
  • [ISSN] 0001-6314
  • [Journal-full-title] Acta neurologica Scandinavica
  • [ISO-abbreviation] Acta Neurol. Scand.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Denmark
  •  go-up   go-down


57. Darling EM, Guilak F: A neural network model for cell classification based on single-cell biomechanical properties. Tissue Eng Part A; 2008 Sep;14(9):1507-15
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In this study, a neural network modeling approach was developed to classify mesenchymal-derived primary and stem cells based on their biomechanical properties.
  • Heterogeneous populations of zonal chondrocytes, chondrosarcoma cells, and mesenchymal-lineage cells, respectively, could all be classified into enriched subpopulations.
  • Additionally, adult stem cells (adipose-derived or bone marrow-derived) separated disproportionately into nodes associated with the three primary mesenchymal lineages examined.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cytometry. 2001 Jul 1;44(3):195-209 [11429770.001]
  • [Cites] J Biomech. 2008;41(2):454-64 [17825308.001]
  • [Cites] Mol Biol Cell. 2002 Dec;13(12):4279-95 [12475952.001]
  • [Cites] J Orthop Res. 2004 Jan;22(1):131-9 [14656671.001]
  • [Cites] Anat Rec A Discov Mol Cell Evol Biol. 2004 Jan;276(1):75-102 [14699636.001]
  • [Cites] J Cell Sci. 2004 Feb 29;117(Pt 6):889-97 [14762107.001]
  • [Cites] Biochem Biophys Res Commun. 2004 May 21;318(1):119-24 [15110761.001]
  • [Cites] Pathology. 2004 Jun;36(3):230-3 [15203726.001]
  • [Cites] Oncogene. 2004 Sep 20;23(43):7188-98 [15378079.001]
  • [Cites] J Orthop Res. 2004 Nov;22(6):1182-7 [15475195.001]
  • [Cites] Cytometry. 1996 Apr 1;23(4):290-302 [8900472.001]
  • [Cites] Biorheology. 1997 Jul-Oct;34(4-5):309-26 [9578806.001]
  • [Cites] Eur Biophys J. 1999;28(4):312-6 [10394623.001]
  • [Cites] Biophys J. 2005 May;88(5):3689-98 [15722433.001]
  • [Cites] Clin Orthop Relat Res. 2000 Jul;(376):291-303 [10906887.001]
  • [Cites] J Histochem Cytochem. 2000 Oct;48(10):1307-20 [10990485.001]
  • [Cites] J Orthop Res. 2000 Nov;18(6):891-8 [11192248.001]
  • [Cites] Ann N Y Acad Sci. 2005 Jun;1044:183-200 [15958712.001]
  • [Cites] Science. 1996 Nov 8;274(5289):998-1001 [8875945.001]
  • [Cites] J Cell Physiol. 2006 Jan;206(1):229-37 [16021633.001]
  • [Cites] Osteoarthritis Cartilage. 2006 Jun;14(6):571-9 [16478668.001]
  • [Cites] J Microbiol Methods. 2006 Aug;66(2):336-46 [16480784.001]
  • [Cites] Nature. 2006 Jun 29;441(7097):1179-85 [16810261.001]
  • [Cites] J Cell Physiol. 2006 Dec;209(3):987-95 [16972251.001]
  • [Cites] Biophys J. 2007 Mar 1;92(5):1784-91 [17158567.001]
  • [Cites] Semin Cancer Biol. 2007 Jun;17(3):257-64 [16814562.001]
  • [Cites] Arthritis Res Ther. 2007;9(1):204 [17316462.001]
  • [Cites] ASAIO J. 2007 Mar-Apr;53(2):219-28 [17413564.001]
  • [Cites] Tissue Eng. 2007 Apr;13(4):819-29 [17371154.001]
  • [Cites] Biochem Biophys Res Commun. 2007 Jun 22;358(1):99-103 [17482567.001]
  • [Cites] Acta Biomater. 2007 Jul;3(4):413-38 [17540628.001]
  • [Cites] J Biomech. 2007;40(12):2596-603 [17397851.001]
  • [Cites] Tissue Eng. 2007 Oct;13(10):2465-73 [17665999.001]
  • [Cites] Adv Biochem Eng Biotechnol. 2007;106:19-39 [17728993.001]
  • [Cites] Comput Biol Med. 2007 Dec;37(12):1677-89 [17544390.001]
  • [Cites] Biophys J. 2007 Nov 15;93(10):3693-702 [17675345.001]
  • [Cites] Conf Proc IEEE Eng Med Biol Soc. 2007;2007:5823-6 [18003337.001]
  • [Cites] Anal Chem. 2007 Dec 15;79(24):9321-30 [18004819.001]
  • [Cites] Electrophoresis. 2007 Dec;28(24):4713-22 [18008303.001]
  • [Cites] Exp Hematol. 2008 Feb;36(2):224-34 [18023524.001]
  • [Cites] Biophys J. 2002 Feb;82(2):720-7 [11806914.001]
  • (PMID = 18620486.001).
  • [ISSN] 1937-3341
  • [Journal-full-title] Tissue engineering. Part A
  • [ISO-abbreviation] Tissue Eng Part A
  • [Language] ENG
  • [Grant] United States / NIA NIH HHS / AG / AG15768; United States / NIAMS NIH HHS / AR / AR048852-01A2; United States / NIAMS NIH HHS / AR / R01 AR048852; United States / NIA NIH HHS / AG / R01 AG015768-10; United States / NIAMS NIH HHS / AR / F32 AR053448; United States / NIAMS NIH HHS / AR / R01 AR048182; United States / NIAMS NIH HHS / AR / K99 AR054673; United States / NIBIB NIH HHS / EB / T32 EB001630-02; United States / NIAMS NIH HHS / AR / P01 AR050245-05; United States / NIAMS NIH HHS / AR / AR50245; United States / NIAMS NIH HHS / AR / AR54673; United States / NIAMS NIH HHS / AR / P01 AR050245; United States / NIA NIH HHS / AG / R01 AG015768; United States / NCRR NIH HHS / RR / UL1 RR024128; United States / NIAMS NIH HHS / AR / AR53448; United States / NIAMS NIH HHS / AR / AR48182; United States / NIAMS NIH HHS / AR / AR048182-03; United States / NIAMS NIH HHS / AR / F32 AR053448-01; United States / NIA NIH HHS / AG / R01 AG015768-11; United States / NIBIB NIH HHS / EB / T32 EB001630; United States / NIA NIH HHS / AG / AG015768-11; United States / NIAMS NIH HHS / AR / P01 AR050245-06; United States / NIAMS NIH HHS / AR / AR48852; United States / NIAMS NIH HHS / AR / AR054673-01A1; United States / NIAMS NIH HHS / AR / R01 AR048182-03; United States / NIAMS NIH HHS / AR / R01 AR048852-01A2; United States / NIAMS NIH HHS / AR / R00 AR054673; United States / NIA NIH HHS / AG / AG015768-10; United States / NIAMS NIH HHS / AR / AR053448-01; United States / NCRR NIH HHS / RR / RR024128; United States / NIBIB NIH HHS / EB / EB001630-02; United States / NIAMS NIH HHS / AR / R01 AR048852-02; United States / NIAMS NIH HHS / AR / K99 AR054673-01A1
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS132889; NLM/ PMC2748927
  •  go-up   go-down


58. Sigauke E, Rakheja D, Maddox DL, Hladik CL, White CL, Timmons CF, Raisanen J: Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol; 2006 May;19(5):717-25
MedlinePlus Health Information. consumer health - Kidney Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In total, 12 brain, three renal and two soft tissue rhabdoid tumors were examined along with four glioblastomas, four pilocytic astrocytomas, four oligodendrogliomas, two ependymomas, two choroid plexus papillomas, five pituitary adenomas, four germinomas, four renal carcinomas with Xp11.2 translocations, two clear cell sarcomas, two Wilms' tumors, one renal medullary carcinoma, two desmoplastic small round cell tumors, two alveolar rhabdomyosarcomas, two embryonal rhabdomyosarcomas, one low-grade chondrosarcoma, two extraskeletal myxoid chondrosarcomas, one mesenchymal chondrosarcoma, four malignant peripheral nerve sheath tumors, five metastatic carcinomas and four epithelioid sarcomas, two primary and two metastatic.
  • [MeSH-minor] Adolescent. Adult. Brain Neoplasms / metabolism. Brain Neoplasms / pathology. Child. Child, Preschool. Chromosomal Proteins, Non-Histone. Diagnosis, Differential. Female. Humans. Immunohistochemistry. Infant. Infant, Newborn. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16528370.001).
  • [ISSN] 0893-3952
  • [Journal-full-title] Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
  • [ISO-abbreviation] Mod. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Chromosomal Proteins, Non-Histone; 0 / DNA-Binding Proteins; 0 / SMARCB1 protein, human; 0 / Transcription Factors
  •  go-up   go-down


59. Ducimetière F, Lurkin A, Ranchère-Vince D, Decouvelaere AV, Isaac S, Claret-Tournier C, Suignard Y, Salameire D, Cellier D, Alberti L, Bringuier PP, Blay JY, Ray-Coquard I: [Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region]. Bull Cancer; 2010 Jun;97(6):629-41
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Sarcomas comprise a heterogeneous group of mesenchymal neoplasms.
  • This review includes a discussion of both soft tissue sarcomas (unclassified sarcoma, liposarcoma, leiomyosarcoma, synovial sarcoma, dermatofibrosarcoma protuberans, angiosarcoma, Kaposi sarcoma, gastrointestinal stromal tumor, rhabdomyosarcoma, ...) and primary bone sarcomas (osteosarcoma, Ewing sarcoma and chondrosarcoma).
  • [MeSH-minor] Adult. Child. Female. France / epidemiology. Humans. Incidence. Male. Risk Factors


60. Feiz-Erfan I, Han PP, Spetzler RF, Porter RW, Klopfenstein JD, Ferreira MA, Beals SP, Joganic EF: Exposure of midline cranial base without a facial incision through a combined craniofacial-transfacial procedure. Neurosurgery; 2005 Jan;56(1 Suppl):28-35; discussion 28-35
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Between 1992 and 1998, eight patients underwent surgery for five different anterior cranial base pathological findings: four angiofibromas, one mesenchymal chondrosarcoma, one esthesioneuroblastoma, one odontogenic myxoma, and one encephalocele.
  • [MeSH-minor] Adolescent. Adult. Child. Craniotomy / methods. Encephalocele / radiography. Encephalocele / surgery. Female. Follow-Up Studies. Humans. Male. Skull Base Neoplasms / radiography. Skull Base Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15799790.001).
  • [ISSN] 1524-4040
  • [Journal-full-title] Neurosurgery
  • [ISO-abbreviation] Neurosurgery
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


61. Looi A, Kazim M, Cortes M, Rootman J: Orbital reconstruction after eyelid- and conjunctiva-sparing orbital exenteration. Ophthal Plast Reconstr Surg; 2006 Jan-Feb;22(1):1-6
COS Scholar Universe. author profiles.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Two patients required surgery for invasive optic nerve sheath meningioma, one for hemangiopericytoma, and the fourth for mesenchymal chondrosarcoma.
  • [MeSH-minor] Adult. Aged. Child. Eye Neoplasms / surgery. Female. Follow-Up Studies. Humans. Male. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Plastic and Cosmetic Surgery.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16418657.001).
  • [ISSN] 0740-9303
  • [Journal-full-title] Ophthalmic plastic and reconstructive surgery
  • [ISO-abbreviation] Ophthal Plast Reconstr Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


62. Oruckaptan HH, Sarac S, Gedikoglu G: Primary intracranial myxoma of the lateral skull base: a rare entity in clinical practice. Turk Neurosurg; 2010 Jan;20(1):86-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Myxomas are rare benign tumors arising from mesenchymal tissues throughout the body.
  • The patient underwent a skull base surgery with a pre-diagnosis of possible chondrosarcoma.
  • [MeSH-minor] Adult. Humans. Immunohistochemistry. Keratins / analysis. Male. Mitosis. Skull / pathology. Temporal Bone / pathology. Temporal Bone / radiography

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20066630.001).
  • [ISSN] 1019-5149
  • [Journal-full-title] Turkish neurosurgery
  • [ISO-abbreviation] Turk Neurosurg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Turkey
  • [Chemical-registry-number] 68238-35-7 / Keratins
  •  go-up   go-down


63. Hamada H, Taskin Yücel O, Engin H, Sungur A: Mesenchymal chondrosarcoma of the nasopharynx. Otolaryngol Head Neck Surg; 2005 Oct;133(4):639
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma of the nasopharynx.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Nasopharyngeal Neoplasms / diagnosis
  • [MeSH-minor] Adult. Humans. Male

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16213946.001).
  • [ISSN] 0194-5998
  • [Journal-full-title] Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
  • [ISO-abbreviation] Otolaryngol Head Neck Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


64. Stránský P, Hora M, Eret V, Klecka J, Urge T, Grégrová H, Dvoráková E, Hes O, Chudácek Z, Kreuzberg B: [Laparoscopic adrenalectomy]. Rozhl Chir; 2009 Sep;88(9):514-20

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We found 3 metastases of renal carcinoma in adrenal gland and one metastasis mesenchymal chondrosarcoma too.
  • [MeSH-minor] Adrenal Gland Neoplasms / surgery. Adult. Aged. Female. Humans. Male. Middle Aged

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20052929.001).
  • [ISSN] 0035-9351
  • [Journal-full-title] Rozhledy v chirurgii : měsíčník Československé chirurgické společnosti
  • [ISO-abbreviation] Rozhl Chir
  • [Language] cze
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Czech Republic
  •  go-up   go-down


65. Wang J, Yin J, Zou C, Xie X, Huang G, Li H, Shen J, Han S: [Surgical treatment of proximal femoral malignant tumors]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 Jul;24(7):881-4
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In 41 patients with primary malignant tumors having a disease course of 0.5-14.0 months, there were 16 cases of osteosarcoma, 7 cases of fibrosarcoma, 6 cases of chondrosarcoma, 6 cases of malignant fibrous histiocytoma, 4 cases of mesenchymal sarcoma,1 case of Ewing sarcoma, and 1 case of angiosarcoma, including 3 cases of type IB, 2 cases of type IIA, 35 cases of type IIB, and 1 case of type III according to Enneking stage.
  • [MeSH-minor] Adolescent. Adult. Aged. Female. Humans. Male. Middle Aged. Retrospective Studies. Treatment Outcome. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20695391.001).
  • [ISSN] 1002-1892
  • [Journal-full-title] Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery
  • [ISO-abbreviation] Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi
  • [Language] chi
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] China
  •  go-up   go-down


66. Tien N, Chaisuparat R, Fernandes R, Sarlani E, Papadimitriou JC, Ord RA, Nikitakis NG: Mesenchymal chondrosarcoma of the maxilla: case report and literature review. J Oral Maxillofac Surg; 2007 Jun;65(6):1260-6
Genetic Alliance. consumer health - Chondrosarcoma.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Mesenchymal chondrosarcoma of the maxilla: case report and literature review.
  • [MeSH-major] Chondrosarcoma, Mesenchymal / diagnosis. Maxillary Neoplasms / diagnosis
  • [MeSH-minor] Adult. Diagnosis, Differential. Follow-Up Studies. Humans. Male. Maxillary Sinus / pathology. Neoplasm Invasiveness. Neoplasm Staging. Oral Ulcer / diagnosis. Orbit / pathology. Palate / pathology. Radiotherapy, Adjuvant

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17517320.001).
  • [ISSN] 0278-2391
  • [Journal-full-title] Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons
  • [ISO-abbreviation] J. Oral Maxillofac. Surg.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 29
  •  go-up   go-down


67. Mustafaev DM, Zenger VG, Ashurov ZM, Selin VN, Alyshov FA, Afzaĭesh D, Kopchenko OO, Akhmedov IN: [Advanced mesenchymal maxillary chondrosarcoma in a young patient]. Vestn Otorinolaringol; 2008;(2):84-5
MedlinePlus Health Information. consumer health - Bone Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Advanced mesenchymal maxillary chondrosarcoma in a young patient].
  • [MeSH-major] Bone Neoplasms / pathology. Bone Neoplasms / radiography. Chondrosarcoma, Mesenchymal / pathology. Chondrosarcoma, Mesenchymal / radiography. Maxillary Neoplasms / pathology. Maxillary Neoplasms / radiography
  • [MeSH-minor] Adult. Endoscopy. Female. Humans. Neoplasm Staging. Tomography, X-Ray Computed

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18454088.001).
  • [ISSN] 0042-4668
  • [Journal-full-title] Vestnik otorinolaringologii
  • [ISO-abbreviation] Vestn. Otorinolaringol.
  • [Language] rus
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Russia (Federation)
  •  go-up   go-down


68. Aksoy S, Abali H, Kiliçkap S, Güler N: Successful treatment of a chemoresistant tumor with temozolomide in an adult patient: report of a recurrent intracranial mesenchymal chondrosarcoma. J Neurooncol; 2005 Feb;71(3):333-4
The Lens. Cited by Patents in .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Successful treatment of a chemoresistant tumor with temozolomide in an adult patient: report of a recurrent intracranial mesenchymal chondrosarcoma.
  • [MeSH-major] Antineoplastic Agents, Alkylating / therapeutic use. Bone Neoplasms / drug therapy. Brain Neoplasms / drug therapy. Chondrosarcoma, Mesenchymal / drug therapy. Dacarbazine / analogs & derivatives. Dacarbazine / therapeutic use. Drug Resistance, Neoplasm / drug effects. Neoplasm Recurrence, Local / drug therapy
  • [MeSH-minor] Adult. Humans. Male. Treatment Outcome

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • MedlinePlus Health Information. consumer health - Bone Cancer.
  • MedlinePlus Health Information. consumer health - Brain Tumors.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • Hazardous Substances Data Bank. DACARBAZINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15735926.001).
  • [ISSN] 0167-594X
  • [Journal-full-title] Journal of neuro-oncology
  • [ISO-abbreviation] J. Neurooncol.
  • [Language] eng
  • [Publication-type] Case Reports; Letter
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Antineoplastic Agents, Alkylating; 7GR28W0FJI / Dacarbazine; 85622-93-1 / temozolomide
  •  go-up   go-down


69. Liu J, Guo HX, Yuan L, He ZY: [Extraskeletal mesenchymal chondrosarcoma of nasal cavity: report of a case]. Zhonghua Bing Li Xue Za Zhi; 2009 Mar;38(3):204-5
MedlinePlus Health Information. consumer health - Nasal Cancer.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Extraskeletal mesenchymal chondrosarcoma of nasal cavity: report of a case].
  • [MeSH-major] Chondrosarcoma, Mesenchymal / pathology. Nasal Cavity. Nose Neoplasms / pathology
  • [MeSH-minor] Adult. Antigens, CD / metabolism. Cell Adhesion Molecules / metabolism. Diagnosis, Differential. Hemangiopericytoma / pathology. Humans. Lymphoma / pathology. Male. Neuroectodermal Tumors, Primitive / pathology. Vimentin / metabolism. Young Adult

  • Genetic Alliance. consumer health - Chondrosarcoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19575863.001).
  • [ISSN] 0529-5807
  • [Journal-full-title] Zhonghua bing li xue za zhi = Chinese journal of pathology
  • [ISO-abbreviation] Zhonghua Bing Li Xue Za Zhi
  • [Language] chi
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] China
  • [Chemical-registry-number] 0 / Antigens, CD; 0 / CD99 protein, human; 0 / Cell Adhesion Molecules; 0 / Vimentin
  •  go-up   go-down






Advertisement